{"filepath": "../L2M3_data/0_csd_related_papers/ACS_XML/cg5b01839.xml", "publisher": "acs", "elements": [{"idx": 1, "type": "text", "classification": ["else"], "content": "<p>Two\nsodium salts (Na\u00ad(CH<sub>3</sub>CH<sub>2</sub>OH) (HReb) (<bold>1</bold>) and Na<sub>2</sub>(H<sub>2</sub>O)<sub>4</sub>(Reb) (<bold>2</bold>)), one methanol solvate (H<sub>2</sub>Reb\u00b7CH<sub>3</sub>OH\n(<bold>3</bold>)), and one methyl ester (<bold>4</bold>) of the\nminimally soluble drug, rebamipide (H<sub>2</sub>Reb), used for the\ntreatment of gastric ulcers and gastritis have been synthesized. For\nthe first time the structure of rebamipide has been determined by\nsingle crystal X-ray diffraction. Although salts <bold>1</bold> and <bold>2</bold> were prepared under the similar conditions, their structures\nare different. In <bold>1</bold>, rebamipide loses the proton of the\ncarboxyl group to interact with the sodium ion, but in <bold>2</bold> the drug molecule converts to its prototropic tautomer and then\nsimultaneously loses the protons of the carboxyl and hydroxyl groups\nto form salt. Control experiments show that reaction temperature is\nthe key factor influencing the formation of salts. Although all methanol\nwas used in the synthesis of <bold>3</bold> and <bold>4</bold>, in <bold>3</bold> methanol acts as solvent involved in the lattice, while\nin <bold>4</bold> it reacts with rebamipide to form ester. By analyzing\nthe mass spectra of the reaction solution, we speculate that the crystallization\nof <bold>3</bold> and <bold>4</bold> is controlled by the product\u2019s\nsolubility. Dissolution studies indicate that both the maximum solubility\nand dissolution rate of <bold>1</bold>\u2013<bold>4</bold> in simulated\nsuccus gastricus are improved. Furthermore, pharmacokinetic behavior\nof compounds <bold>1</bold>\u2013<bold>4</bold> was investigated\nin rats and the results indicate that the bioavailability of <bold>1</bold>, <bold>3</bold>, and <bold>4</bold> upon oral administration\nis enhanced compared to that of API.</p>", "clean_text": "Two sodium salts (Na(CH3CH2OH) (HReb) (1) and Na2(H2O)4(Reb) (2)), one methanol solvate (H2Reb\u22c5CH3OH (3)), and one methyl ester (4) of the minimally soluble drug, rebamipide (H2Reb), used for the treatment of gastric ulcers and gastritis have been synthesized. For the first time the structure of rebamipide has been determined by single crystal X-ray diffraction. Although salts 1 and 2 were prepared under the similar conditions, their structures are different. In 1, rebamipide loses the proton of the carboxyl group to interact with the sodium ion, but in 2 the drug molecule converts to its prototropic tautomer and then simultaneously loses the protons of the carboxyl and hydroxyl groups to form salt. Control experiments show that reaction temperature is the key factor influencing the formation of salts. Although all methanol was used in the synthesis of 3 and 4, in 3 methanol acts as solvent involved in the lattice, while in 4 it reacts with rebamipide to form ester. By analyzing the mass spectra of the reaction solution, we speculate that the crystallization of 3 and 4 is controlled by the product's solubility. Dissolution studies indicate that both the maximum solubility and dissolution rate of 1-4 in simulated succus gastricus are improved. Furthermore, pharmacokinetic behavior of compounds 1-4 was investigated in rats and the results indicate that the bioavailability of 1, 3, and 4 upon oral administration is enhanced compared to that of API.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 2, "type": "text", "classification": ["else"], "content": "<p>Sodium salts (<bold>1</bold> and <bold>2</bold>), methanol\nsolvate (<bold>3</bold>), and methyl ester (<bold>4</bold>) of rebamipide\nused for treatment of gastric ulcers have been prepared and thoroughly\ncharacterized. The syntheses of <bold>1</bold>, <bold>2</bold> and <bold>3</bold>, <bold>4</bold> are controlled by temperature and solubility,\nrespectively. Dissolution and pharmacokinetic studies indicate that\nthe solubility and oral absorption of <bold>1</bold>, <bold>3</bold>, and <bold>4</bold> are enhanced.</p>", "clean_text": "Sodium salts (1 and 2), methanol solvate (3), and methyl ester (4) of rebamipide used for treatment of gastric ulcers have been prepared and thoroughly characterized. The syntheses of 1, 2 and 3, 4 are controlled by temperature and solubility, respectively. Dissolution and pharmacokinetic studies indicate that the solubility and oral absorption of 1, 3, and 4 are enhanced.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 3, "type": "text", "classification": ["else"], "content": "<title>Introduction</title><p>Rebamipide, an amino acid derivative of\n2-(1<italic>H</italic>)-quinolinone,\nis a therapeutic agent for gastric ulcers and chronic gastritis. It\nwas first synthesized by Otsuka Pharmaceutical Company, Ltd. in 1985 and subsequently marketed with the trade name\nof Mucosta in 1990. The molecular structure of rebamipide is shown\nin . This drug\ncan stimulate the generation of endogenous prostaglandins in the gastric\nmucosa, thereby facilitating and accelerating ulcer healing. In addition, recent clinical studies display\nthat rebamipide can effectively treat stomatitis, colitis, and dry\neye syndrome. According to the Biopharmaceutics Classification\nSystem (BCS), rebamipide belongs to the Class IV drugs, which have\nlow solubility and low permeability. Rebamipide\nis nearly insoluble in most common organic solvents and its solubility\nin water is approximately 0.0001 and 0.013% (w/v) at pH 3 and 7, respectively. As a result, the absorption of this drug is poor\nwith the absolute bioavailability of about 10%.\n</p>", "clean_text": "Introduction\n\nRebamipide, an amino acid derivative of 2-(1H)-quinolinone, is a therapeutic agent for gastric ulcers and chronic gastritis. It was first synthesized by Otsuka Pharmaceutical Company, Ltd. in 1985 and subsequently marketed with the trade name of Mucosta in 1990. The molecular structure of rebamipide is shown in . This drug can stimulate the generation of endogenous prostaglandins in the gastric mucosa, thereby facilitating and accelerating ulcer healing. In addition, recent clinical studies display that rebamipide can effectively treat stomatitis, colitis, and dry eye syndrome. According to the Biopharmaceutics Classification System (BCS), rebamipide belongs to the Class IV drugs, which have low solubility and low permeability. Rebamipide is nearly insoluble in most common organic solvents and its solubility in water is approximately 0.0001 and 0.013% (w/v) at pH 3 and 7, respectively. As a result, the absorption of this drug is poor with the absolute bioavailability of about 10%. ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 4, "type": "figure", "classification": null, "content": "<fig fig-type=\"scheme\" id=\"sch1\" position=\"float\">\n<label>1</label>\n<caption>\n<title>Molecular Structure of Rebamipide</title>\n</caption>\n<graphic id=\"gr1\" position=\"float\" xlink:href=\"cg-2015-01839n_0012.tif\"></graphic>\n</fig>", "clean_text": " 1  Molecular Structure of Rebamipide   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 5, "type": "text", "classification": ["else"], "content": "<p>Recently, solid state forms, referring to polymorphs,\nsolvates\n(or hydrates), salts, cocrystals, or amorphous forms, play an important\nrole in the pharmaceutical field. A lot of studies demonstrate\nthat many physical and chemical properties of an active pharmaceutical\ningredient (API), such as stability, solubility, and bioavailability, are influenced by the selection and optimization\nof solid state forms. The reported solid state forms of rebamipide\ninclude one monohydrate, two cocrystals, and several salts. Forming salt is the classic method for improving solubility and\ndissolution rate of acidic/basic APIs. Although choline, arginine, lysine, tromethamine, sodium, calcium,\nzinc, and magnesium salts of rebamipide were synthesized in patent,\nno structural characterization was provided. With the existence of two acidic functional groups in rebamipide,\na carboxylic acid and a <italic>N</italic>-heterocycle, it is not\neasy to predict the product when reacting with alkaline agents. A\ncareful literature and Cambridge Structural Database (CSD) search\nindicates that although rebamipide has been widely investigated since\n1985, so far no crystal structure of rebamipide or its salt, hydrate,\nsolvate, or cocrystal is reported. However, unambiguous structural\ncharacterization is necessary in the development of a drug, which\nis helpful to build the structure\u2013property relationship and\nguide the controllable synthesis.</p>", "clean_text": "Recently, solid state forms, referring to polymorphs, solvates (or hydrates), salts, cocrystals, or amorphous forms, play an important role in the pharmaceutical field. A lot of studies demonstrate that many physical and chemical properties of an active pharmaceutical ingredient (API), such as stability, solubility, and bioavailability, are influenced by the selection and optimization of solid state forms. The reported solid state forms of rebamipide include one monohydrate, two cocrystals, and several salts. Forming salt is the classic method for improving solubility and dissolution rate of acidic/basic APIs. Although choline, arginine, lysine, tromethamine, sodium, calcium, zinc, and magnesium salts of rebamipide were synthesized in patent, no structural characterization was provided. With the existence of two acidic functional groups in rebamipide, a carboxylic acid and a N-heterocycle, it is not easy to predict the product when reacting with alkaline agents. A careful literature and Cambridge Structural Database (CSD) search indicates that although rebamipide has been widely investigated since 1985, so far no crystal structure of rebamipide or its salt, hydrate, solvate, or cocrystal is reported. However, unambiguous structural characterization is necessary in the development of a drug, which is helpful to build the structure-property relationship and guide the controllable synthesis.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 6, "type": "text", "classification": ["else"], "content": "<p>Herein, for the first time\nwe determine the crystal structures\nof two rebamipide sodium salts, namely Na\u00ad(CH<sub>3</sub>CH<sub>2</sub>OH) (HReb) (<bold>1</bold>) and Na<sub>2</sub>(H<sub>2</sub>O)<sub>4</sub>(Reb) (<bold>2</bold>), and one methanol solvate, H<sub>2</sub>Reb\u00b7CH<sub>3</sub>OH (<bold>3</bold>) (H<sub>2</sub>Reb = rebamipide).\nMoreover, during the screening of solid state form, the single crystal\nof rebamipide methyl ester (<bold>4</bold>) has been fortunately obtained.\nIn addition, compounds <bold>1</bold>\u2013<bold>4</bold> have been\ncharacterized by powder X-ray diffraction, Fourier transform-infrared\nspectroscopy (FT-IR), thermogravimetry, and differential scanning\ncalorimetry. It is notable that both the maximum solubility and bioavailability\nof <bold>1</bold>, <bold>3</bold>, and <bold>4</bold> are enhanced\ncompared to those of API.</p>", "clean_text": "Herein, for the first time we determine the crystal structures of two rebamipide sodium salts, namely Na(CH3CH2OH) (HReb) (1) and Na2(H2O)4(Reb) (2), and one methanol solvate, H2Reb\u22c5CH3OH (3) (H2Reb = rebamipide). Moreover, during the screening of solid state form, the single crystal of rebamipide methyl ester (4) has been fortunately obtained. In addition, compounds 1-4 have been characterized by powder X-ray diffraction, Fourier transform-infrared spectroscopy (FT-IR), thermogravimetry, and differential scanning calorimetry. It is notable that both the maximum solubility and bioavailability of 1, 3, and 4 are enhanced compared to those of API.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 7, "type": "text", "classification": ["else"], "content": "<title>Experimental Section</title><title>Materials\nand General Methods</title><p>Rebamipide (purity &gt;98%)\nwas provided by Research Center for Drug Metabolism of Jilin University\nand used without further purification. The other chemicals were reagent\ngrade, purchased from commercial sources, and used without further\npurification. IR spectra were obtained (as KBr-pressed pellets) using\na Nicolet 170SXFT/IR spectrometer in the range of 500\u20134000\ncm<sup>\u20131</sup>. Powder X-ray diffraction (PXRD) data were\ncollected on a Bruker instrument equipped with graphite-monochromatized\nCu K\u03b1 radiation\n(\u03bb = 0.154060 nm, scan speed = 8\u00b0/min, 2\u03b8 = 5\u201335\u00b0,\nstepsize = 0.019762). TG analyses were carried out in nitrogen atmosphere\nbetween 30 and 350 \u00b0C at a heating rate of 10 \u00b0C/min on\na SDT Q600 simultaneous thermal analyzer. Differential scanning calorimetry\nwas performed on a Q100 DSC module with nitrogen flow rate of 50 mL\u00b7min<sup>\u20131</sup>. <sup>1</sup>H NMR spectra were recorded using a\nBruker-400 NMR spectrometer. Mass spectra were recorded in the positive\nmode on an Agilent 6520 Q-TOF LC/MS mass spectrometer. Sample solutions\nwere made to approximately 10<sup>\u20136</sup> M in ultrapurified\nwater or methanol and transferred to the electrospray source via an\nautosampler with a flow rate of 0.2 mL/min.</p>", "clean_text": "Experimental Section\n\nMaterials and General Methods\n\nRebamipide (purity >98%) was provided by Research Center for Drug Metabolism of Jilin University and used without further purification. The other chemicals were reagent grade, purchased from commercial sources, and used without further purification. IR spectra were obtained (as KBr-pressed pellets) using a Nicolet 170SXFT/IR spectrometer in the range of 500-4000 cm-1. Powder X-ray diffraction (PXRD) data were collected on a Bruker instrument equipped with graphite-monochromatized Cu K\u03b1 radiation (\u03bb = 0.154060 nm, scan speed = 8\u00b0/min, 2\u03b8 = 5-35\u00b0, stepsize = 0.019762). TG analyses were carried out in nitrogen atmosphere between 30 and 350 \u00b0C at a heating rate of 10 \u00b0C/min on a SDT Q600 simultaneous thermal analyzer. Differential scanning calorimetry was performed on a Q100 DSC module with nitrogen flow rate of 50 mL\u22c5min-1. 1H NMR spectra were recorded using a Bruker-400 NMR spectrometer. Mass spectra were recorded in the positive mode on an Agilent 6520 Q-TOF LC/MS mass spectrometer. Sample solutions were made to approximately 10-6 M in ultrapurified water or methanol and transferred to the electrospray source via an autosampler with a flow rate of 0.2 mL/min.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 8, "type": "text", "classification": ["synthesis condition"], "content": "<title>Synthesis of Na\u00ad(CH<sub>3</sub>CH<sub>2</sub>OH) (HReb) (<bold>1</bold>)</title><p>Rebamipide\n(100 mg, 0.27 mmol) was dissolved in\n15 mL ethanol and then stirred for 2 h. To this was added 0.075 mL\nNaOH (5 M) with vigorously stirring. The resulting solution was filtered\nand allowed for slow evaporation under ambient conditions. Colorless\nblock single crystals of <bold>1</bold> suitable for single X-ray\ndiffraction were obtained and dried under ambient conditions (yield\nof 95 mg, \u223c80% based on rebamipide).</p>", "clean_text": "Synthesis of Na(CH3CH2OH) (HReb) (1)\n\nRebamipide (100 mg, 0.27 mmol) was dissolved in 15 mL ethanol and then stirred for 2 h. To this was added 0.075 mL NaOH (5 M) with vigorously stirring. The resulting solution was filtered and allowed for slow evaporation under ambient conditions. Colorless block single crystals of 1 suitable for single X-ray diffraction were obtained and dried under ambient conditions (yield of 95 mg, ~80% based on rebamipide).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition']"}}, {"idx": 9, "type": "text", "classification": ["synthesis condition"], "content": "<title>Synthesis of Na<sub>2</sub>(H<sub>2</sub>O)<sub>4</sub>(Reb)\n(<bold>2</bold>)</title><p>Compound <bold>2</bold> was prepared using\na procedure similar to that for <bold>1</bold>. The only difference\nis that the mixture of rebamipide and sodium hydroxide solution was\nheated at 50 \u00b0C for 30 min, then filtered and allowed for crystallization.\nAfter 1 day, colorless needle-like single crystals of <bold>2</bold> were isolated and dried at ambient conditions (yield of 98 mg, \u223c75%\nbased on rebamipide).</p>", "clean_text": "Synthesis of Na2(H2O)4(Reb) (2)\n\nCompound 2 was prepared using a procedure similar to that for 1. The only difference is that the mixture of rebamipide and sodium hydroxide solution was heated at 50 \u00b0C for 30 min, then filtered and allowed for crystallization. After 1 day, colorless needle-like single crystals of 2 were isolated and dried at ambient conditions (yield of 98 mg, ~75% based on rebamipide).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition']"}}, {"idx": 10, "type": "text", "classification": ["synthesis condition"], "content": "<title>Synthesis of H<sub>2</sub>Reb\u00b7CH<sub>3</sub>OH (<bold>3</bold>)</title><p>Rebamipide (45 mg, 0.12 mmol)\nwas dissolved in 15 mL methanol\nand stirred for 2 h. The solution was then transferred to a Teflon-lined\nautoclave (15 mL) and kept at 120 \u00b0C for 48 h. After the mixture\nwas slowly cooled to room temperature, the resulting solution was\nfiltered and slowly evaporated at ambient conditions. After 2 days,\ncolorless needle-shaped crystals of <bold>3</bold> were harvested\n(yield of 40 mg, \u223c82% based on rebamipide) and one single crystal\nwas chosen for X-ray analysis.</p>", "clean_text": "Synthesis of H2Reb\u22c5CH3OH (3)\n\nRebamipide (45 mg, 0.12 mmol) was dissolved in 15 mL methanol and stirred for 2 h. The solution was then transferred to a Teflon-lined autoclave (15 mL) and kept at 120 \u00b0C for 48 h. After the mixture was slowly cooled to room temperature, the resulting solution was filtered and slowly evaporated at ambient conditions. After 2 days, colorless needle-shaped crystals of 3 were harvested (yield of 40 mg, ~82% based on rebamipide) and one single crystal was chosen for X-ray analysis.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition']"}}, {"idx": 11, "type": "text", "classification": ["synthesis condition"], "content": "<title>Synthesis of Rebamipide\nMethyl Ester (<bold>4</bold>)</title><p>Compound <bold>4</bold> was\nsynthesized using a procedure similar\nto that of <bold>3</bold>. The only difference is that the API was\ndissolved in the methanol-H<sub>2</sub>O (v:v = 3:1) solution. The\nobtained solution was heated at 120 \u00b0C in a Teflon-lined autoclave\n(15 mL) for 48 h, and then the resulting solution was allowed to evaporate\nat ambient conditions. Colorless block crystals of <bold>4</bold> were\nisolated after about 7 days (yield 35 mg, \u223c75% based on rebamipide). <sup>1</sup>H NMR (DMSO-<italic>d</italic>\n<sub>6</sub>, 400 MHz) \u03b4\n(ppm) 11.66 (1H, s, imino group), 9.03 (1H, d, imino group), 7.21\u20137.85\n(8H, m, phenyl), 6.44 (1H, s, alkenyl), 4.35 (1H, t, methine), 3.69\n(3H, s, methyl), 2.06 (2H, s, methylene). (<ext-link xlink:href=\"http://pubs.acs.org/doi/suppl/10.1021/acs.cgd.5b01839/suppl_file/cg5b01839_si_001.pdf\">Supporting Information</ext-link>, Figure S1)</p>", "clean_text": "Synthesis of Rebamipide Methyl Ester (4)\n\nCompound 4 was synthesized using a procedure similar to that of 3. The only difference is that the API was dissolved in the methanol-H2O (v:v = 3:1) solution. The obtained solution was heated at 120 \u00b0C in a Teflon-lined autoclave (15 mL) for 48 h, and then the resulting solution was allowed to evaporate at ambient conditions. Colorless block crystals of 4 were isolated after about 7 days (yield 35 mg, ~75% based on rebamipide). 1H NMR (DMSO-d 6, 400 MHz) \u03b4 (ppm) 11.66 (1H, s, imino group), 9.03 (1H, d, imino group), 7.21-7.85 (8H, m, phenyl), 6.44 (1H, s, alkenyl), 4.35 (1H, t, methine), 3.69 (3H, s, methyl), 2.06 (2H, s, methylene). (Supporting Information, Figure S1)", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition']"}}, {"idx": 12, "type": "text", "classification": ["else"], "content": "<title>Single Crystal X-ray Diffraction</title><p>The single crystal\ndata for compounds <bold>1</bold>\u2013<bold>4</bold> were collected\non a Bruker-AXS CCD diffractometer equipped with a Mo K\u03b1 radiation\nsource (\u03bb = 0.07103 \u00c5) at 298 K. The absorption corrections\nwere performed with the SADABS program. The structures were determined\nby direct methods and expanded using Fourier techniques. The non-hydrogen\natoms were refined anisotropically. The H atoms on C atoms were fixed\nat the calculated positions and those on the water molecules were\nlocated from the different Fourier maps. The H atoms were isotropically\nrefined. All calculations were performed using the SHELXTL-97 program. CCDC-<ext-link ext-link-type=\"ccdc\" xlink:href=\"1439505\">1439505</ext-link> (<bold>1</bold>) <ext-link ext-link-type=\"ccdc\" xlink:href=\"1404896\">1404896</ext-link> (<bold>2</bold>) <ext-link ext-link-type=\"ccdc\" xlink:href=\"1404894\">1404894</ext-link> (<bold>3</bold>) and <ext-link ext-link-type=\"ccdc\" xlink:href=\"1439500\">1439500</ext-link> (<bold>4</bold>) contain the supplementary crystallographic\ndata for this paper. The crystallographic details of the compounds\nare summarized in . The hydrogen bonding distances and angles are present in  and the selected\nbond length and angles are given in <ext-link xlink:href=\"http://pubs.acs.org/doi/suppl/10.1021/acs.cgd.5b01839/suppl_file/cg5b01839_si_001.pdf\">Table S2</ext-link>.</p>", "clean_text": "Single Crystal X-ray Diffraction\n\nThe single crystal data for compounds 1-4 were collected on a Bruker-AXS CCD diffractometer equipped with a Mo K\u03b1 radiation source (\u03bb = 0.07103 \u00c5) at 298 K. The absorption corrections were performed with the SADABS program. The structures were determined by direct methods and expanded using Fourier techniques. The non-hydrogen atoms were refined anisotropically. The H atoms on C atoms were fixed at the calculated positions and those on the water molecules were located from the different Fourier maps. The H atoms were isotropically refined. All calculations were performed using the SHELXTL-97 program. CCDC-1439505 (1) 1404896 (2) 1404894 (3) and 1439500 (4) contain the supplementary crystallographic data for this paper. The crystallographic details of the compounds are summarized in . The hydrogen bonding distances and angles are present in  and the selected bond length and angles are given in Table S2.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 13, "type": "table", "classification": null, "content": "<table-wrap id=\"tbl1\" position=\"float\">\n<label>1</label>\n<caption>\n<title>Crystallographic Data for Compounds <bold>1</bold>\u2013<bold>4</bold>\n<xref rid=\"t1fn1\"></xref>\n</title>\n</caption>\n<oasis:table colsep=\"0\" rowsep=\"0\">\n<oasis:tgroup cols=\"5\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col3\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col4\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col5\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\"></oasis:entry>\n<oasis:entry align=\"center\">1</oasis:entry>\n<oasis:entry align=\"center\">2</oasis:entry>\n<oasis:entry align=\"center\">3</oasis:entry>\n<oasis:entry align=\"center\">4</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>formula</oasis:entry>\n<oasis:entry>C<sub>21</sub>H<sub>20</sub>ClN<sub>2</sub>NaO<sub>5</sub>\n</oasis:entry>\n<oasis:entry>C<sub>19</sub>H<sub>21</sub>ClN<sub>2</sub>Na<sub>2</sub>O<sub>8</sub>\n</oasis:entry>\n<oasis:entry>C<sub>20</sub>H<sub>19</sub>ClN<sub>2</sub>O<sub>5</sub>\n</oasis:entry>\n<oasis:entry>C<sub>20</sub>H<sub>17</sub>ClN<sub>2</sub>O<sub>4</sub>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>formula weight</oasis:entry>\n<oasis:entry>438.83</oasis:entry>\n<oasis:entry>486.81</oasis:entry>\n<oasis:entry>402.82</oasis:entry>\n<oasis:entry>384.81</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>crystal\nsystem</oasis:entry>\n<oasis:entry>monoclinic</oasis:entry>\n<oasis:entry>orthorhombic</oasis:entry>\n<oasis:entry>monoclinic</oasis:entry>\n<oasis:entry>monoclinic</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>space group</oasis:entry>\n<oasis:entry>\n<italic>P</italic>21/<italic>c</italic>\n</oasis:entry>\n<oasis:entry>\n<italic>Pna</italic>2(1)</oasis:entry>\n<oasis:entry>\n<italic>C</italic>2/<italic>c</italic>\n</oasis:entry>\n<oasis:entry>\n<italic>P</italic>21<italic>c</italic>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>a</italic> (\u00c5)</oasis:entry>\n<oasis:entry>6.014(2)</oasis:entry>\n<oasis:entry>34.551(3)</oasis:entry>\n<oasis:entry>23.030(2)</oasis:entry>\n<oasis:entry>19.7573(15)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>b</italic> (\u00c5)</oasis:entry>\n<oasis:entry>23.279(9)</oasis:entry>\n<oasis:entry>5.0944(4)</oasis:entry>\n<oasis:entry>19.1331(18)</oasis:entry>\n<oasis:entry>5.0379(3)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>c</italic> (\u00c5)</oasis:entry>\n<oasis:entry>15.076(6)</oasis:entry>\n<oasis:entry>12.0785(11)</oasis:entry>\n<oasis:entry>9.6060(9)</oasis:entry>\n<oasis:entry>19.5600(12)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b1 (deg)</oasis:entry>\n<oasis:entry>90</oasis:entry>\n<oasis:entry>90</oasis:entry>\n<oasis:entry>90</oasis:entry>\n<oasis:entry>90</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b2\n(deg)</oasis:entry>\n<oasis:entry>99.969(7)</oasis:entry>\n<oasis:entry>90</oasis:entry>\n<oasis:entry>106.358(2)</oasis:entry>\n<oasis:entry>109.887(7)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b3 (deg)</oasis:entry>\n<oasis:entry>90</oasis:entry>\n<oasis:entry>90</oasis:entry>\n<oasis:entry>90</oasis:entry>\n<oasis:entry>90</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>Z</italic>\n</oasis:entry>\n<oasis:entry>4</oasis:entry>\n<oasis:entry>4</oasis:entry>\n<oasis:entry>8</oasis:entry>\n<oasis:entry>4</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>volume (\u00c5<sup>3</sup>)</oasis:entry>\n<oasis:entry>2078.9(14)</oasis:entry>\n<oasis:entry>2126.0(3)</oasis:entry>\n<oasis:entry>4061.4(7)</oasis:entry>\n<oasis:entry>1830.8(2)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>D</italic>\n<sub>calc</sub> (g\u00b7cm<sup>\u20133</sup>)</oasis:entry>\n<oasis:entry>1.402</oasis:entry>\n<oasis:entry>1.521</oasis:entry>\n<oasis:entry>1.318</oasis:entry>\n<oasis:entry>1.396</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>F</italic> (000)</oasis:entry>\n<oasis:entry>912</oasis:entry>\n<oasis:entry>1008</oasis:entry>\n<oasis:entry>1680</oasis:entry>\n<oasis:entry>800</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>refns. collected</oasis:entry>\n<oasis:entry>10139</oasis:entry>\n<oasis:entry>9761</oasis:entry>\n<oasis:entry>10191</oasis:entry>\n<oasis:entry>8493</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>unique reflns.</oasis:entry>\n<oasis:entry>3637</oasis:entry>\n<oasis:entry>2869</oasis:entry>\n<oasis:entry>3572</oasis:entry>\n<oasis:entry>3382</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>R</italic>\n<sub>int</sub>\n</oasis:entry>\n<oasis:entry>0.0447</oasis:entry>\n<oasis:entry>0.0708</oasis:entry>\n<oasis:entry>0.0599</oasis:entry>\n<oasis:entry>0.0258</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>R</italic>\n<sub>1</sub>[<italic>I</italic>\u00a0&gt;\u00a02\u03c3(<italic>I</italic>)]</oasis:entry>\n<oasis:entry>0.0634</oasis:entry>\n<oasis:entry>0.0470</oasis:entry>\n<oasis:entry>0.0612</oasis:entry>\n<oasis:entry>0.0651</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>wR</italic>\n<sub>2</sub>[<italic>I</italic>\u00a0&gt;\u00a02\u03c3(<italic>I</italic>)]</oasis:entry>\n<oasis:entry>0.2021</oasis:entry>\n<oasis:entry>0.1020</oasis:entry>\n<oasis:entry>0.1437</oasis:entry>\n<oasis:entry>0.1702</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>R</italic>\n<sub>1</sub>(all data)</oasis:entry>\n<oasis:entry>0.1092</oasis:entry>\n<oasis:entry>0.0581</oasis:entry>\n<oasis:entry>0.1261</oasis:entry>\n<oasis:entry>0.0898</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>wR</italic>\n<sub>2</sub> (all data)</oasis:entry>\n<oasis:entry>0.2620</oasis:entry>\n<oasis:entry>0.1056</oasis:entry>\n<oasis:entry>0.1618</oasis:entry>\n<oasis:entry>0.1877</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>GOF on <italic>F</italic>\n<sup>2</sup>\n</oasis:entry>\n<oasis:entry>1.052</oasis:entry>\n<oasis:entry>1.060</oasis:entry>\n<oasis:entry>1.044</oasis:entry>\n<oasis:entry>1.065</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n<table-wrap-foot>\n<fn id=\"t1fn1\">\n<label>a</label>\n<p>\n<italic>R</italic>\n<sub>1</sub> =\n\u2211| |<italic>F</italic>\n<sub>o</sub>| \u2013 |<italic>F</italic>\n<sub>c</sub>| |/\u2211|<italic>F</italic>\n<sub>o</sub>|; <italic>wR</italic>\n<sub>2</sub> = \u2211[<italic>w</italic>(<italic>F</italic>\n<sub>o</sub>\n<sup>2</sup> \u2013 <italic>F</italic>\n<sub>c</sub>\n<sup>2</sup>)<sup>2</sup>]/\u2211[<italic>w</italic>(<italic>F</italic>\n<sub>o</sub>\n<sup>2</sup>)<sup>2</sup>]<sup>1/2</sup>\n</p>\n</fn>\n</table-wrap-foot>\n</table-wrap>", "clean_text": "", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 14, "type": "table", "classification": null, "content": "<table-wrap id=\"tbl2\" position=\"float\">\n<label>2</label>\n<caption>\n<title>Hydrogen Bonding\nInteractions in Compounds <bold>1</bold>\u2013<bold>4</bold>\n</title>\n</caption>\n<oasis:table colsep=\"0\" rowsep=\"0\">\n<oasis:tgroup cols=\"6\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col3\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col4\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col5\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col6\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\">D\u2013H\u00b7\u00b7\u00b7A</oasis:entry>\n<oasis:entry align=\"center\">D\u2013H/\u00c5</oasis:entry>\n<oasis:entry align=\"center\">H\u00b7\u00b7\u00b7A/\u00c5</oasis:entry>\n<oasis:entry align=\"center\">D\u00b7\u00b7\u00b7A/\u00c5</oasis:entry>\n<oasis:entry align=\"center\">D\u2013H\u00b7\u00b7\u00b7A/\u00b0</oasis:entry>\n<oasis:entry align=\"center\">symmetry code</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>compound <bold>1</bold>\n</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>N1\u2013H1\u00b7\u00b7\u00b7O1</oasis:entry>\n<oasis:entry>0.860</oasis:entry>\n<oasis:entry>2.004</oasis:entry>\n<oasis:entry>2.858</oasis:entry>\n<oasis:entry>172.05</oasis:entry>\n<oasis:entry>\u2013x+2, \u2013y+1, -z+1</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>N2\u2013H2A\u00b7\u00b7\u00b7O1</oasis:entry>\n<oasis:entry>0.860</oasis:entry>\n<oasis:entry>2.338</oasis:entry>\n<oasis:entry>3.102</oasis:entry>\n<oasis:entry>148.23</oasis:entry>\n<oasis:entry>x\u20131, y, z</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>O5\u2013H5A\u00b7\u00b7\u00b7O4</oasis:entry>\n<oasis:entry>0.849</oasis:entry>\n<oasis:entry>1.818</oasis:entry>\n<oasis:entry>2.685</oasis:entry>\n<oasis:entry>169.92</oasis:entry>\n<oasis:entry>x\u20131, y, z</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>compound <bold>2</bold>\n</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>N2\u2013H2A\u00b7\u00b7\u00b7O2</oasis:entry>\n<oasis:entry>0.860</oasis:entry>\n<oasis:entry>2.333</oasis:entry>\n<oasis:entry>3.175</oasis:entry>\n<oasis:entry>166.11</oasis:entry>\n<oasis:entry>x, y\u20131, z</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>O5\u2013H5A\u00b7\u00b7\u00b7O1</oasis:entry>\n<oasis:entry>0.970</oasis:entry>\n<oasis:entry>1.886</oasis:entry>\n<oasis:entry>2.720</oasis:entry>\n<oasis:entry>142.54</oasis:entry>\n<oasis:entry>\u2013x+1, \u2212y, z\u20131/2</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>O5\u2013H5B\u00a0\u00b7\u00b7\u00b7N1</oasis:entry>\n<oasis:entry>0.970</oasis:entry>\n<oasis:entry>2.492</oasis:entry>\n<oasis:entry>3.203</oasis:entry>\n<oasis:entry>130.03</oasis:entry>\n<oasis:entry>\u2013x+1, \u2013y+1, z\u20131/2</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>O6\u2013H6A\u00b7\u00b7\u00b7N1</oasis:entry>\n<oasis:entry>0.850</oasis:entry>\n<oasis:entry>2.078</oasis:entry>\n<oasis:entry>2.920</oasis:entry>\n<oasis:entry>170.47</oasis:entry>\n<oasis:entry>x, y\u20131, z</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>O6\u2013H6B\u00b7\u00b7\u00b7O4</oasis:entry>\n<oasis:entry>0.850</oasis:entry>\n<oasis:entry>2.036</oasis:entry>\n<oasis:entry>2.839</oasis:entry>\n<oasis:entry>157.29</oasis:entry>\n<oasis:entry>\u2013x+1, \u2212y, z\u20131/2</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>O7\u2013H7A\u00b7\u00b7\u00b7O8</oasis:entry>\n<oasis:entry>0.970</oasis:entry>\n<oasis:entry>1.964</oasis:entry>\n<oasis:entry>2.726</oasis:entry>\n<oasis:entry>133.78</oasis:entry>\n<oasis:entry>intramolecular</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>O7\u2013H7B\u00b7\u00b7\u00b7N1</oasis:entry>\n<oasis:entry>0.970</oasis:entry>\n<oasis:entry>2.262</oasis:entry>\n<oasis:entry>2.871</oasis:entry>\n<oasis:entry>119.81</oasis:entry>\n<oasis:entry>\u2013x+1,\n\u2212y, z\u20131/2</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>O8\u2013H8A\u00b7\u00b7\u00b7O4</oasis:entry>\n<oasis:entry>0.852</oasis:entry>\n<oasis:entry>1.922</oasis:entry>\n<oasis:entry>2.772</oasis:entry>\n<oasis:entry>174.68</oasis:entry>\n<oasis:entry>\u2013x+1, \u2212y, z\u20131/2</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>O8\u2013H8B\u00b7\u00b7\u00b7O2</oasis:entry>\n<oasis:entry>0.851</oasis:entry>\n<oasis:entry>1.961</oasis:entry>\n<oasis:entry>2.785</oasis:entry>\n<oasis:entry>162.71</oasis:entry>\n<oasis:entry>\u2013x+1, \u2013y+1, z\u20131/2</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>compound <bold>3</bold>\n</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>N1\u2013H1\u00b7\u00b7\u00b7O3</oasis:entry>\n<oasis:entry>0.860</oasis:entry>\n<oasis:entry>2.026</oasis:entry>\n<oasis:entry>2.883</oasis:entry>\n<oasis:entry>174.03</oasis:entry>\n<oasis:entry>\u2013x+3/2,y+1/2,\u2013z+1/2</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>N2\u2013H2A\u00b7\u00b7\u00b7O2</oasis:entry>\n<oasis:entry>0.860</oasis:entry>\n<oasis:entry>2.122</oasis:entry>\n<oasis:entry>2.869</oasis:entry>\n<oasis:entry>144.90</oasis:entry>\n<oasis:entry>x, \u2013y+1, z\u20131/2</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>O4\u2013H4B\u00b7\u00b7\u00b7O5</oasis:entry>\n<oasis:entry>0.850</oasis:entry>\n<oasis:entry>1.782</oasis:entry>\n<oasis:entry>2.609</oasis:entry>\n<oasis:entry>163.88</oasis:entry>\n<oasis:entry>intramolecular</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>O5\u2013H5A\u00b7\u00b7\u00b7O1</oasis:entry>\n<oasis:entry>0.820</oasis:entry>\n<oasis:entry>1.979</oasis:entry>\n<oasis:entry>2.701</oasis:entry>\n<oasis:entry>146.53</oasis:entry>\n<oasis:entry>\u2013x+3/2,y\u20131/2, \u2013z+1/2</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>O5\u2013H5B\u00b7\u00b7\u00b7O1</oasis:entry>\n<oasis:entry>0.850</oasis:entry>\n<oasis:entry>2.018</oasis:entry>\n<oasis:entry>2.701</oasis:entry>\n<oasis:entry>136.78</oasis:entry>\n<oasis:entry>\u2013x+3/2,y\u20131/2, \u2013z+1/2</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>compound <bold>4</bold>\n</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>N1\u2013H1\u00b7\u00b7\u00b7O1</oasis:entry>\n<oasis:entry>0.860</oasis:entry>\n<oasis:entry>1.972</oasis:entry>\n<oasis:entry>2.826</oasis:entry>\n<oasis:entry>172.10</oasis:entry>\n<oasis:entry>x, y\u20131, z</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>N2\u2013H2A\u00b7\u00b7\u00b7O2</oasis:entry>\n<oasis:entry>0.860</oasis:entry>\n<oasis:entry>2.007</oasis:entry>\n<oasis:entry>2.923</oasis:entry>\n<oasis:entry>167.62</oasis:entry>\n<oasis:entry>\u2013x,y+1/2,\u2013z\u20131/2</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n</table-wrap>", "clean_text": "", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 15, "type": "text", "classification": ["else"], "content": "<title>Dissolution and Solubility</title><p>The absorbance of a known\nconcentration of rebamipide was measured at the given \u03bb<sub>max</sub> (228 nm) using a TU-1901 UV\u2013vis spectrometer. The\nabsorbance values were plotted against several known concentrations\nto prepare the concentration vs intensity calibration curve (R<sup>2</sup> = 0.9996). From the slopes of the calibration curves, the\nmolar extinction coefficients of compounds <bold>1</bold>\u2013<bold>4</bold> were calculated. The rebamipide derivatives were milled\nto powders and sieved using standard mesh sieves to provide samples\nwith the approximate particle size distribution of 75\u2013150 \u03bcm.\nIn order to determine the equilibrium solubility, an excess amount\nof compound was added to 10 mL of simulated gastric fluid media (HCl\nsolution with pH = 1.2). The supersaturated solution was stirred (50\nrpm) at room temperature. The suspension was filtered through a 0.22\n\u03bcm nylon filter after 24 h. The filtered aliquots were diluted\nand the absorbance was measured at the given \u03bb<sub>max</sub>.</p>", "clean_text": "Dissolution and Solubility\n\nThe absorbance of a known concentration of rebamipide was measured at the given \u03bbmax (228 nm) using a TU-1901 UV-vis spectrometer. The absorbance values were plotted against several known concentrations to prepare the concentration vs intensity calibration curve (R2 = 0.9996). From the slopes of the calibration curves, the molar extinction coefficients of compounds 1-4 were calculated. The rebamipide derivatives were milled to powders and sieved using standard mesh sieves to provide samples with the approximate particle size distribution of 75-150 \u03bcm. In order to determine the equilibrium solubility, an excess amount of compound was added to 10 mL of simulated gastric fluid media (HCl solution with pH = 1.2). The supersaturated solution was stirred (50 rpm) at room temperature. The suspension was filtered through a 0.22 \u03bcm nylon filter after 24 h. The filtered aliquots were diluted and the absorbance was measured at the given \u03bbmax.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 16, "type": "text", "classification": ["else"], "content": "<p>In the dissolution experiment, 50 mL of HCl solution (pH\n= 1.2) was added to a 100 mL flask containing excess powder samples,\nand the resulting mixture was stirred at 25 \u00b0C and 500 rpm. The\nsolution was withdrawn from the flask at regular intervals and filtered\nthrough a 0.22 \u03bcm nylon filter. The concentration of the aliquots\nwas determined with appropriate dilutions measured with UV\u2013vis\nspectrophotometry. Each experiment was conducted three times and the\nmean value in each case was calculated.</p>", "clean_text": "In the dissolution experiment, 50 mL of HCl solution (pH = 1.2) was added to a 100 mL flask containing excess powder samples, and the resulting mixture was stirred at 25 \u00b0C and 500 rpm. The solution was withdrawn from the flask at regular intervals and filtered through a 0.22 \u03bcm nylon filter. The concentration of the aliquots was determined with appropriate dilutions measured with UV-vis spectrophotometry. Each experiment was conducted three times and the mean value in each case was calculated.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 17, "type": "text", "classification": "error", "content": "<title>Pharmacokinetic Study (PK)</title><p>The pharmacokinetics of\ncompounds <bold>1</bold>\u2013<bold>4</bold> and original API were\nconducted using Wistar rats. After an overnight fast, 15 healthy rats\n(7 months, weighing 220\u2013260 g) were randomly divided into five\ngroups before dosing. Pure powder samples of rebamipide API and compounds <bold>1</bold>\u2013<bold>4</bold> as oral formulations were administered\nto rats in different groups by gastric perfusion using a dry powder\ninsufflator at a single dose of 12 mg/kg for each group. Subsequently,\n0.5 mL aliquots of whole blood samples were collected from the eyeball\nveins at intervals of 0.17, 0.33, 0.5, 0.75, 1, 2, 3, 5, 7, 9, 11,\nand 24 h from each rat, immediately centrifuged for 5 min at 13300\nrpm at ambient temperature, and stored at \u221220 \u00b0C until\nLC\u2013MS/MS analysis. Analysis was performed on a LC\u2013MS/MS\nsystem comprising Agilent 1100 Series HPLC system (Agilent Technologies,\nPalo Alto, CA, USA) and a Q-trap 2000 mass spectrometer (Applied BiosystemsSciex,\nOntario, Canada). Chromatographic separation was achieved using an\nAgilent ZORBAX 300 SB-C18 column (150 mm \u00d7 4.6 mm I.D., 5 \u03bcm\nparticle size) at 40 \u00b0C with a mobile phase of formic acid/water\n(v/v = 70:30) at 1 mL/min. Analysis was carried out with an electrospray\nionization (ESI) source using positive ion mode. Data were acquired\nusing Drug and Statistics Software DAS 3.0 (Mathematical Pharmacology\nProfessional Committee of China, Shanghai, China). The hydrolysis\nexperiment of compound <bold>4</bold> in vivo has been performed using\nthe similar method.</p>", "clean_text": "Pharmacokinetic Study (PK)\n\nThe pharmacokinetics of compounds 1-4 and original API were conducted using Wistar rats. After an overnight fast, 15 healthy rats (7 months, weighing 220-260 g) were randomly divided into five groups before dosing. Pure powder samples of rebamipide API and compounds 1-4 as oral formulations were administered to rats in different groups by gastric perfusion using a dry powder insufflator at a single dose of 12 mg/kg for each group. Subsequently, 0.5 mL aliquots of whole blood samples were collected from the eyeball veins at intervals of 0.17, 0.33, 0.5, 0.75, 1, 2, 3, 5, 7, 9, 11, and 24 h from each rat, immediately centrifuged for 5 min at 13300 rpm at ambient temperature, and stored at -20 \u00b0C until LC-MS/MS analysis. Analysis was performed on a LC-MS/MS system comprising Agilent 1100 Series HPLC system (Agilent Technologies, Palo Alto, CA, USA) and a Q-trap 2000 mass spectrometer (Applied BiosystemsSciex, Ontario, Canada). Chromatographic separation was achieved using an Agilent ZORBAX 300 SB-C18 column (150 mm \u00d7 4.6 mm I.D., 5 \u03bcm particle size) at 40 \u00b0C with a mobile phase of formic acid/water (v/v = 70:30) at 1 mL/min. Analysis was carried out with an electrospray ionization (ESI) source using positive ion mode. Data were acquired using Drug and Statistics Software DAS 3.0 (Mathematical Pharmacology Professional Committee of China, Shanghai, China). The hydrolysis experiment of compound 4 in vivo has been performed using the similar method.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 18, "type": "text", "classification": "error", "content": "<title>Results and Discussion</title><title>Crystal Structure of Na\u00ad(CH<sub>3</sub>CH<sub>2</sub>OH) (HReb)\n(<bold>1</bold>)</title><p>When reacting with NaOH solution, rebamipide\nloses the proton of the carboxylic acid group to form salt <bold>1</bold>. As shown in , the asymmetric unit of salt <bold>1</bold> consists of one Na<sup>+</sup>, one ethanol molecule, and one [HReb]<sup>\u2212</sup>.\nIn the rebamipide anion, the dihedral angle between quinolinone and\nchlorobenzene ring is 78.87\u00b0. The Na<sup>+</sup> ion exhibits\na distorted tetrahedral geometry and coordinates with two oxygen atoms\nof carboxyl groups (O3, O4) from different drug molecules, one oxygen\natom of acylamino group (O2), and one oxygen atom of ethanol (O5)\n(a). Two Na<sup>+</sup> cations link two adjacent rebamipide ions to form an 8-membered\nring. These 8-membered rings are connected by the Na1\u2013O2 coordination\nbonds into a 1D chain along <italic>a</italic>-axis (a). In this case, Na\u2013O\ndistances are in the range of 2.290\u20132.343 \u00c5. In addition,\nN1\u2013H\u00b7\u00b7\u00b7O1 hydrogen bond interactions extend\nthe 1D chain into a 2D layer on the <italic>ac</italic>-plane (b).</p>", "clean_text": "Results and Discussion\n\nCrystal Structure of Na(CH3CH2OH) (HReb) (1)\n\nWhen reacting with NaOH solution, rebamipide loses the proton of the carboxylic acid group to form salt 1. As shown in , the asymmetric unit of salt 1 consists of one Na+, one ethanol molecule, and one [HReb]-. In the rebamipide anion, the dihedral angle between quinolinone and chlorobenzene ring is 78.87\u00b0. The Na+ ion exhibits a distorted tetrahedral geometry and coordinates with two oxygen atoms of carboxyl groups (O3, O4) from different drug molecules, one oxygen atom of acylamino group (O2), and one oxygen atom of ethanol (O5) (a). Two Na+ cations link two adjacent rebamipide ions to form an 8-membered ring. These 8-membered rings are connected by the Na1-O2 coordination bonds into a 1D chain along a-axis (a). In this case, Na-O distances are in the range of 2.290-2.343 \u00c5. In addition, N1-H\u22c5\u22c5\u22c5O1 hydrogen bond interactions extend the 1D chain into a 2D layer on the ac-plane (b).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 19, "type": "figure", "classification": null, "content": "<fig id=\"fig1\" position=\"float\">\n<label>1</label>\n<caption>\n<p>An asymmetric unit of\nsalt <bold>1</bold>.</p>\n</caption>\n<graphic id=\"gr4\" position=\"float\" xlink:href=\"cg-2015-01839n_0002.tif\"></graphic>\n</fig>", "clean_text": " 1  An asymmetric unit of salt 1.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 20, "type": "figure", "classification": null, "content": "<fig id=\"fig2\" position=\"float\">\n<label>2</label>\n<caption>\n<p>(a) 1D chain in salt <bold>1</bold>. (b) 2D supermolecular network\nformed by hydrogen bonding interactions of N1\u2013H\u00b7\u00b7\u00b7O3.\nH atoms are omitted for the sake of clarity and green dashed lines\nrepresent the hydrogen bonding interactions.</p>\n</caption>\n<graphic id=\"gr5\" position=\"float\" xlink:href=\"cg-2015-01839n_0003.tif\"></graphic>\n</fig>", "clean_text": " 2  (a) 1D chain in salt 1. (b) 2D supermolecular network formed by hydrogen bonding interactions of N1-H\u22c5\u22c5\u22c5O3. H atoms are omitted for the sake of clarity and green dashed lines represent the hydrogen bonding interactions.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 21, "type": "text", "classification": ["else"], "content": "<title>Crystal Structure of Na<sub>2</sub>(H<sub>2</sub>O)<sub>4</sub>(Reb)\n(<bold>2</bold>)</title><p>When rebamipide reacts with NaOH\naqueous under heating conditions, another sodium salt <bold>2</bold> is isolated. As shown in , there are two Na<sup>+</sup>, four coordinated water\nmolecules, and one [Reb]<sup>2\u2013</sup> in the asymmetric unit\nof <bold>2</bold>. Compared with <bold>1</bold>, two obvious differences\nare found in this case. First, prototropic tautomerism is observed\nin the quinolinone part and as a result the amide form transforms\nto an imidic acid form (). Second, rebamipide loses two protons: one from a carboxyl\ngroup and the other from a hydroxyl group, to coordinate with sodium\ncations.</p>", "clean_text": "Crystal Structure of Na2(H2O)4(Reb) (2)\n\nWhen rebamipide reacts with NaOH aqueous under heating conditions, another sodium salt 2 is isolated. As shown in , there are two Na+, four coordinated water molecules, and one [Reb]2- in the asymmetric unit of 2. Compared with 1, two obvious differences are found in this case. First, prototropic tautomerism is observed in the quinolinone part and as a result the amide form transforms to an imidic acid form (). Second, rebamipide loses two protons: one from a carboxyl group and the other from a hydroxyl group, to coordinate with sodium cations.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 22, "type": "figure", "classification": null, "content": "<fig id=\"fig3\" position=\"float\">\n<label>3</label>\n<caption>\n<p>An asymmetric unit of salt <bold>2</bold>.</p>\n</caption>\n<graphic id=\"gr6\" position=\"float\" xlink:href=\"cg-2015-01839n_0004.tif\"></graphic>\n</fig>", "clean_text": " 3  An asymmetric unit of salt 2.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 23, "type": "figure", "classification": null, "content": "<fig fig-type=\"scheme\" id=\"sch2\" position=\"float\">\n<label>2</label>\n<caption>\n<title>Equilibrium between Two Tautomers</title>\n</caption>\n<graphic id=\"gr2\" position=\"float\" xlink:href=\"cg-2015-01839n_0013.tif\"></graphic>\n</fig>", "clean_text": " 2  Equilibrium between Two Tautomers   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 24, "type": "text", "classification": ["else"], "content": "<p>There are two crystallographically independent Na ions\nin <bold>2</bold>. Na1 coordinates with one carboxyl oxygen (O3),\none hydroxyl\noxygen (O1), and two water molecules (O5, O6) with seesaw-shaped geometry.\nNa2 adopts a distorted square geometry bonding with one hydroxyl oxygen\n(O1) and three water molecules (O5, O7, O8). The O1 and O5 acting\nas bridge link adjacent Na1 and Na2 ions into a 1D chain along <italic>c</italic>-axis (a). The weak interaction of Na1\u00b7\u00b7\u00b7O6 with the\ndistance of 2.710 \u00c5 further assembles 1D chains into a 2D sheet\non the <italic>ac</italic>-plane (b,c). Besides the Na\u00b7\u00b7\u00b7O weak\ninteractions, a series of hydrogen bond interactions contribute to\nthe formation of 2D sheet (<ext-link xlink:href=\"http://pubs.acs.org/doi/suppl/10.1021/acs.cgd.5b01839/suppl_file/cg5b01839_si_001.pdf\">Figure S2</ext-link> and ).</p>", "clean_text": "There are two crystallographically independent Na ions in 2. Na1 coordinates with one carboxyl oxygen (O3), one hydroxyl oxygen (O1), and two water molecules (O5, O6) with seesaw-shaped geometry. Na2 adopts a distorted square geometry bonding with one hydroxyl oxygen (O1) and three water molecules (O5, O7, O8). The O1 and O5 acting as bridge link adjacent Na1 and Na2 ions into a 1D chain along c-axis (a). The weak interaction of Na1\u22c5\u22c5\u22c5O6 with the distance of 2.710 \u00c5 further assembles 1D chains into a 2D sheet on the ac-plane (b,c). Besides the Na\u22c5\u22c5\u22c5O weak interactions, a series of hydrogen bond interactions contribute to the formation of 2D sheet (Figure S2 and ).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 25, "type": "figure", "classification": null, "content": "<fig id=\"fig4\" position=\"float\">\n<label>4</label>\n<caption>\n<p>(a) 1D chain in salt <bold>2</bold>. (b) 2D sheet formed by Na\u00b7\u00b7\u00b7O\nweak interactions on <italic>bc</italic> plane. (c) The view of the\n2D sheet along <italic>b</italic>-axis. H atoms are omitted for the\nsake of clarity and green-blue dashed lines represent the weak Na\u00b7\u00b7\u00b7O\ninteractions.</p>\n</caption>\n<graphic id=\"gr7\" position=\"float\" xlink:href=\"cg-2015-01839n_0005.tif\"></graphic>\n</fig>", "clean_text": " 4  (a) 1D chain in salt 2. (b) 2D sheet formed by Na\u22c5\u22c5\u22c5O weak interactions on bc plane. (c) The view of the 2D sheet along b-axis. H atoms are omitted for the sake of clarity and green-blue dashed lines represent the weak Na\u22c5\u22c5\u22c5O interactions.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 26, "type": "text", "classification": ["else"], "content": "<title>Crystal Structure of H<sub>2</sub>Reb\u00b7CH<sub>3</sub>OH\n(<bold>3</bold>)</title><p>When rebamipide dissolve in methanol under\nsolvothermal conditions, the crystals of solvate <bold>3</bold> were\nobtained. Asymmetric unit of <bold>3</bold> contains one rebamipide\nand one methanol molecule (). The dihedral angle between quinolinone and chlorobenzene\nrings is 62.79\u00b0, which is less than the angles in salts <bold>1</bold> and <bold>2</bold>. As shown in a, a 1D supermolecular chain is generated\nalong <italic>b</italic>-axis with the help of N1\u2013H\u00b7\u00b7\u00b7O3,\nO4\u2013H\u00b7\u00b7\u00b7O5, and O5\u2013H\u00b7\u00b7\u00b7O1\nhydrogen bonds. The neighboring 1D chains are further connected via\nN2\u2013H\u00b7\u00b7\u00b7O2 hydrogen bonds into a 2D sheet on\nthe <italic>bc</italic>-plane ().</p>", "clean_text": "Crystal Structure of H2Reb\u22c5CH3OH (3)\n\nWhen rebamipide dissolve in methanol under solvothermal conditions, the crystals of solvate 3 were obtained. Asymmetric unit of 3 contains one rebamipide and one methanol molecule (). The dihedral angle between quinolinone and chlorobenzene rings is 62.79\u00b0, which is less than the angles in salts 1 and 2. As shown in a, a 1D supermolecular chain is generated along b-axis with the help of N1-H\u22c5\u22c5\u22c5O3, O4-H\u22c5\u22c5\u22c5O5, and O5-H\u22c5\u22c5\u22c5O1 hydrogen bonds. The neighboring 1D chains are further connected via N2-H\u22c5\u22c5\u22c5O2 hydrogen bonds into a 2D sheet on the bc-plane ().", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 27, "type": "figure", "classification": null, "content": "<fig id=\"fig5\" position=\"float\">\n<label>5</label>\n<caption>\n<p>An asymmetric unit of solvate <bold>3</bold>.</p>\n</caption>\n<graphic id=\"gr8\" position=\"float\" xlink:href=\"cg-2015-01839n_0006.tif\"></graphic>\n</fig>", "clean_text": " 5  An asymmetric unit of solvate 3.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 28, "type": "figure", "classification": null, "content": "<fig id=\"fig6\" position=\"float\">\n<label>6</label>\n<caption>\n<p>(a) 1D chain formed by hydrogen bonding in <bold>3</bold>. (b)\n2D supermolecular network on <italic>bc</italic> plane. H atoms are\nomitted for the sake of clarity and green dashed lines represent the\nhydrogen bonding interactions.</p>\n</caption>\n<graphic id=\"gr9\" position=\"float\" xlink:href=\"cg-2015-01839n_0007.tif\"></graphic>\n</fig>", "clean_text": " 6  (a) 1D chain formed by hydrogen bonding in 3. (b) 2D supermolecular network on bc plane. H atoms are omitted for the sake of clarity and green dashed lines represent the hydrogen bonding interactions.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 29, "type": "text", "classification": ["else"], "content": "<title>Rebamipide Methyl Ester (<bold>4</bold>)</title><p>When rebamipide\ndissolves in methanol-H<sub>2</sub>O (V<sub>methanl</sub>:V<sub>water</sub> = 3:1), the crystals of rebamipide methyl ester <bold>4</bold> were\nobtained unexpectedly (a). Rebamipide methyl ester as a prodrug has been synthesized\nthrough the reaction of rebamipide and methyl iodide. However, in our case <bold>4</bold> is prepared by esterification\nof rebamipide with methanol. The dihedral angle between quinolinone\nand chlorobenzene rings in <bold>4</bold> (8.65\u00b0) is much smaller\nthan those in <bold>1</bold>\u2013<bold>3</bold>. As shown in b, the N2\u2013H\u00b7\u00b7\u00b7O2\nhydrogen bonding interactions assemble the organic molecules into\na 1D chain and two adjacent chains are further linked by N1\u2013H\u00b7\u00b7\u00b7O1\nhydrogen bondings to form a double supermolecular chain along <italic>b</italic>-axis.</p>", "clean_text": "Rebamipide Methyl Ester (4)\n\nWhen rebamipide dissolves in methanol-H2O (Vmethanl:Vwater = 3:1), the crystals of rebamipide methyl ester 4 were obtained unexpectedly (a). Rebamipide methyl ester as a prodrug has been synthesized through the reaction of rebamipide and methyl iodide. However, in our case 4 is prepared by esterification of rebamipide with methanol. The dihedral angle between quinolinone and chlorobenzene rings in 4 (8.65\u00b0) is much smaller than those in 1-3. As shown in b, the N2-H\u22c5\u22c5\u22c5O2 hydrogen bonding interactions assemble the organic molecules into a 1D chain and two adjacent chains are further linked by N1-H\u22c5\u22c5\u22c5O1 hydrogen bondings to form a double supermolecular chain along b-axis.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 30, "type": "figure", "classification": null, "content": "<fig id=\"fig7\" position=\"float\">\n<label>7</label>\n<caption>\n<p>(a) An asymmetric unit of rebamipide methyl ester <bold>4</bold>. (b) 1D double chain assembled by hydrogen bonding interactions.</p>\n</caption>\n<graphic id=\"gr10\" position=\"float\" xlink:href=\"cg-2015-01839n_0008.tif\"></graphic>\n</fig>", "clean_text": " 7  (a) An asymmetric unit of rebamipide methyl ester 4. (b) 1D double chain assembled by hydrogen bonding interactions.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 31, "type": "text", "classification": "error", "content": "<p>The formation of rebamipide methyl ester is\nfurther proved by <sup>1</sup>H NMR (<ext-link xlink:href=\"http://pubs.acs.org/doi/suppl/10.1021/acs.cgd.5b01839/suppl_file/cg5b01839_si_001.pdf\">Figure S1</ext-link>). Through the comparison of rebamipide API and its methyl ester,\nit is clear that in <bold>4</bold> the active hydrogen of carboxyl\ngroup with \u03b4 = 13.0 disappears and an additional single peak\nof \u2212CH<sub>3</sub> with \u03b4 = 3.69 is observed. Moreover,\nthe rebamipide peaks are slightly shifted to higher field relative\nto the peaks of API, because of the electron-donating ability of the\nmethyl group.</p>", "clean_text": "The formation of rebamipide methyl ester is further proved by 1H NMR (Figure S1). Through the comparison of rebamipide API and its methyl ester, it is clear that in 4 the active hydrogen of carboxyl group with \u03b4 = 13.0 disappears and an additional single peak of -CH3 with \u03b4 = 3.69 is observed. Moreover, the rebamipide peaks are slightly shifted to higher field relative to the peaks of API, because of the electron-donating ability of the methyl group.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 32, "type": "text", "classification": ["else"], "content": "<title>The Factors Influencing\nthe Synthesis of <bold>1</bold>\u2013<bold>4</bold>\n</title><p>Although\nsodium salts <bold>1</bold> and <bold>2</bold> were all prepared by\nthe reaction of rebamipide ethanol\nsolution and NaOH aqueous, they have totally different structures.\nIn order to explore the controlling factors, the adding order of starting\nmaterial, the amount of NaOH, and reaction temperature were investigated\n(see <ext-link xlink:href=\"http://pubs.acs.org/doi/suppl/10.1021/acs.cgd.5b01839/suppl_file/cg5b01839_si_001.pdf\">Table S1</ext-link>). The results display that\nthe formation of salt <bold>1</bold> or <bold>2</bold> depends on\nthe temperature. As shown in , two tautomers, amide form (in <bold>1</bold>) and\nimidic acid form (in <bold>2</bold>), exist in a chemical equilibrium.\nGenerally, the extra ratio of the isomers is influenced by temperature,\nsolvent, and pH value. The previous study shows that high temperature is beneficial for\nthe formation of imidic acid form. Therefore,\nthe sodium salt <bold>2</bold> based on imidic acid form was isolated\nunder heating conditions, while under room temperature the sodium\nsalt <bold>1</bold> based on amide from was generated. Although the\nprototropic tautomerism is common in heterocycles, to the best of\nour knowledge, the imidic acid form of rebamipide has not been reported.\nMoreover, during our experiment even if the API solution was heated\nin temperature range of 120\u2013160 \u00b0C, we still did not observe\nthe formation of imidic acid form as neutral molecules. Therefore,\nwe speculate that the salt forming process is helpful to stabilize\nthe imidic acid form.</p>", "clean_text": "The Factors Influencing the Synthesis of 1-4 \n\nAlthough sodium salts 1 and 2 were all prepared by the reaction of rebamipide ethanol solution and NaOH aqueous, they have totally different structures. In order to explore the controlling factors, the adding order of starting material, the amount of NaOH, and reaction temperature were investigated (see Table S1). The results display that the formation of salt 1 or 2 depends on the temperature. As shown in , two tautomers, amide form (in 1) and imidic acid form (in 2), exist in a chemical equilibrium. Generally, the extra ratio of the isomers is influenced by temperature, solvent, and pH value. The previous study shows that high temperature is beneficial for the formation of imidic acid form. Therefore, the sodium salt 2 based on imidic acid form was isolated under heating conditions, while under room temperature the sodium salt 1 based on amide from was generated. Although the prototropic tautomerism is common in heterocycles, to the best of our knowledge, the imidic acid form of rebamipide has not been reported. Moreover, during our experiment even if the API solution was heated in temperature range of 120-160 \u00b0C, we still did not observe the formation of imidic acid form as neutral molecules. Therefore, we speculate that the salt forming process is helpful to stabilize the imidic acid form.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 33, "type": "text", "classification": ["else"], "content": "<p>Compounds <bold>3</bold> and <bold>4</bold> are all crystallized from the rebamipide solution prepared under\nsolvothermal conditions (120 \u00b0C for 48 h). The only difference\nis that the solvent used in <bold>3</bold> is methanol, but that in <bold>4</bold> is methanol-H<sub>2</sub>O with volume ratio of 3:1. In <bold>3</bold>, methanol as a solvent is involved in the lattice, but in <bold>4</bold>, methanol acts as a reactant to form ester with API molecule.\nIn order to explore the key factor controlling the formation of <bold>3</bold> and <bold>4</bold>, the reaction solutions of <bold>3</bold> and <bold>4</bold> are characterized by ESI-MS. The analyses of\nthe positive mode mass spectra display that both API with <italic>m</italic>/<italic>z</italic> = 371.09 and methyl ester of rebamipide\nwith <italic>m</italic>/<italic>z</italic> = 385. 09 are detected\nin solution and in the two cases the main products are all esters\n(<ext-link xlink:href=\"http://pubs.acs.org/doi/suppl/10.1021/acs.cgd.5b01839/suppl_file/cg5b01839_si_001.pdf\">Figure S3</ext-link>). Why we do not isolate ester\nduring the synthesis of <bold>3</bold>? We speculate that solubility\nis the key factor controlling the crystallization of <bold>3</bold> and <bold>4</bold>. In methanol, the ester is more soluble than\nAPI, so during evaporation API combining with methanol first precipitates\nto form <bold>3</bold> (). As a result, the equilibrium goes backward and more solvate <bold>3</bold> is obtained. However, when deionic water was added, the\nsolubility of ester dramatically decreases, so the ester precipitates\ninstead ().\nWith the precipitation of <bold>4</bold>, the equilibrium moves forward,\nfollowed by the crystallization of <bold>4</bold>. Therefore, the\nharvesting of <bold>3</bold> or <bold>4</bold> is controlled by the\ndynamics and the solubility of API or ester is adjusted by water.</p>", "clean_text": "Compounds 3 and 4 are all crystallized from the rebamipide solution prepared under solvothermal conditions (120 \u00b0C for 48 h). The only difference is that the solvent used in 3 is methanol, but that in 4 is methanol-H2O with volume ratio of 3:1. In 3, methanol as a solvent is involved in the lattice, but in 4, methanol acts as a reactant to form ester with API molecule. In order to explore the key factor controlling the formation of 3 and 4, the reaction solutions of 3 and 4 are characterized by ESI-MS. The analyses of the positive mode mass spectra display that both API with m/z = 371.09 and methyl ester of rebamipide with m/z = 385. 09 are detected in solution and in the two cases the main products are all esters (Figure S3). Why we do not isolate ester during the synthesis of 3? We speculate that solubility is the key factor controlling the crystallization of 3 and 4. In methanol, the ester is more soluble than API, so during evaporation API combining with methanol first precipitates to form 3 (). As a result, the equilibrium goes backward and more solvate 3 is obtained. However, when deionic water was added, the solubility of ester dramatically decreases, so the ester precipitates instead (). With the precipitation of 4, the equilibrium moves forward, followed by the crystallization of 4. Therefore, the harvesting of 3 or 4 is controlled by the dynamics and the solubility of API or ester is adjusted by water.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 34, "type": "figure", "classification": null, "content": "<fig fig-type=\"scheme\" id=\"sch3\" position=\"float\">\n<label>3</label>\n<caption>\n<title>Equilibrium between Rebamipide and its Methyl Ester</title>\n</caption>\n<graphic id=\"gr3\" position=\"float\" xlink:href=\"cg-2015-01839n_0014.tif\"></graphic>\n</fig>", "clean_text": " 3  Equilibrium between Rebamipide and its Methyl Ester   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 35, "type": "text", "classification": ["else"], "content": "<title>The Powder X-ray Diffraction and Thermal\nAnalyses</title><p>PXRD\nis proved to be a reliable technique for assessment of solid forms\nin pharmaceutical study. As shown in <ext-link xlink:href=\"http://pubs.acs.org/doi/suppl/10.1021/acs.cgd.5b01839/suppl_file/cg5b01839_si_001.pdf\">Figure S4</ext-link>, the PXRD patterns of compounds <bold>1</bold>\u2013<bold>4</bold> are obviously different from that of API, proving the formation\nof new solid forms. Moreover, the PXRD patterns of the synthesized\nsamples closely match the simulated ones (<ext-link xlink:href=\"http://pubs.acs.org/doi/suppl/10.1021/acs.cgd.5b01839/suppl_file/cg5b01839_si_001.pdf\">Figure S5</ext-link>).</p>", "clean_text": "The Powder X-ray Diffraction and Thermal Analyses\n\nPXRD is proved to be a reliable technique for assessment of solid forms in pharmaceutical study. As shown in Figure S4, the PXRD patterns of compounds 1-4 are obviously different from that of API, proving the formation of new solid forms. Moreover, the PXRD patterns of the synthesized samples closely match the simulated ones (Figure S5).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 36, "type": "text", "classification": ["property"], "content": "<p>The thermal behaviors of API and compounds <bold>1</bold>\u2013<bold>4</bold> were investigated by differential scanning\ncalorimetry (DSC)\nand thermogravimetric analysis (TGA). The results are presented in . In the DSC and\nTGA plots of <bold>1</bold>, an initial endotherm at 160 \u00b0C corresponds\nto a weight loss of ethanol molecule (obsd.10.40%, calc.10.49%), and\nthe endotherm at 318 \u00b0C is attributed to the decomposition of <bold>1</bold>. For <bold>2</bold>, the TGA curve shows a weight loss of\n14.70% in the 73\u201397 \u00b0C range, which is consistent with\nthe loss of four water molecules (calc.14.79%). Then upon further\nheating, compound <bold>2</bold> decomposes at 267 \u00b0C. The first\nendothermic peak of <bold>3</bold> at 151 \u00b0C is for the loss\nof methanol molecular (obsd.7.98%, calc.7.95%) and <bold>3</bold> decomposes\nat 273 \u00b0C. The melting point of <bold>4</bold> is 269 \u00b0C\nand above this decomposition begins.</p>", "clean_text": "The thermal behaviors of API and compounds 1-4 were investigated by differential scanning calorimetry (DSC) and thermogravimetric analysis (TGA). The results are presented in . In the DSC and TGA plots of 1, an initial endotherm at 160 \u00b0C corresponds to a weight loss of ethanol molecule (obsd.10.40%, calc.10.49%), and the endotherm at 318 \u00b0C is attributed to the decomposition of 1. For 2, the TGA curve shows a weight loss of 14.70% in the 73-97 \u00b0C range, which is consistent with the loss of four water molecules (calc.14.79%). Then upon further heating, compound 2 decomposes at 267 \u00b0C. The first endothermic peak of 3 at 151 \u00b0C is for the loss of methanol molecular (obsd.7.98%, calc.7.95%) and 3 decomposes at 273 \u00b0C. The melting point of 4 is 269 \u00b0C and above this decomposition begins.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['property']"}}, {"idx": 37, "type": "figure", "classification": null, "content": "<fig id=\"fig8\" position=\"float\">\n<label>8</label>\n<caption>\n<p>TG (black) and DSC (red) thermograms of compounds <bold>1</bold>\u2013<bold>4</bold>.</p>\n</caption>\n<graphic id=\"gr11\" position=\"float\" xlink:href=\"cg-2015-01839n_0009.tif\"></graphic>\n</fig>", "clean_text": " 8  TG (black) and DSC (red) thermograms of compounds 1-4.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 38, "type": "text", "classification": "error", "content": "<title>Spectral Analysis</title><p>The structure changes of drug molecules\nin <bold>1</bold>, <bold>2</bold>, and <bold>4</bold> are further\nconfirmed by FT-IR spectroscopy. Generally, the characteristic absorption\npeak of \u2212COOH group is at 1720\u20131700 cm<sup>\u20131</sup>, whereas the ones of \u2212COO<sup>\u2013</sup> group are at\n1650\u20131550 cm<sup>\u20131</sup> (strong) and 1400 cm<sup>\u20131</sup> (weak). The IR spectra of API and compounds <bold>1</bold>\u2013<bold>4</bold> are shown in <ext-link xlink:href=\"http://pubs.acs.org/doi/suppl/10.1021/acs.cgd.5b01839/suppl_file/cg5b01839_si_001.pdf\">Figure S6</ext-link>. The strong\nabsorption peak at 1720 cm<sup>\u20131</sup> in API disappears in\nsalts <bold>1</bold> and <bold>2</bold>. Instead, new absorption peaks\narising from asymmetric and symmetric vibration of carboxylate group\nare observed at 1614 and 1395 cm<sup>\u20131</sup> (for <bold>1</bold>) and 1612 and 1392 cm<sup>\u20131</sup> (for <bold>2</bold>).\nMoreover, the characteristic absorption peaks of ester group at 1156\nand 1088 cm<sup>\u20131</sup> appear in the IR spectrum of <bold>4</bold>.</p>", "clean_text": "Spectral Analysis\n\nThe structure changes of drug molecules in 1, 2, and 4 are further confirmed by FT-IR spectroscopy. Generally, the characteristic absorption peak of -COOH group is at 1720-1700 cm-1, whereas the ones of -COO- group are at 1650-1550 cm-1 (strong) and 1400 cm-1 (weak). The IR spectra of API and compounds 1-4 are shown in Figure S6. The strong absorption peak at 1720 cm-1 in API disappears in salts 1 and 2. Instead, new absorption peaks arising from asymmetric and symmetric vibration of carboxylate group are observed at 1614 and 1395 cm-1 (for 1) and 1612 and 1392 cm-1 (for 2). Moreover, the characteristic absorption peaks of ester group at 1156 and 1088 cm-1 appear in the IR spectrum of 4.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 39, "type": "text", "classification": "error", "content": "<title>Dissolution Study and Stability</title><p>Powder dissolution\nprofiles of rebamipide API and compounds <bold>1</bold>\u2013<bold>4</bold> in simulated succus gastricus (HCl solution with pH = 1.2)\nare shown in . It is found that both the dissolution rate and apparent solubilities\nof <bold>1</bold>\u2013<bold>4</bold> are higher than those of API.\nAll the compounds reach their maximum solubility (<italic>S</italic>\n<sub>max</sub>) within 17 min and <italic>S</italic>\n<sub>max</sub> is enhanced by 4.05, 4.73, 3.21, and 1.23 times for <bold>1</bold>\u2013<bold>4</bold>, respectively, compared to that of API (a). Then the solubilities\nof <bold>1</bold>\u2013<bold>3</bold> began to decrease and after\n36 h the solubility of each compound was close to that of API (b). Similar phenomena\nhave been reported by Lu T. B. et al. The left solid samples of the dissolution experiments\nwere collected and characterized by PXRD. The PXRD patterns display\nthat compounds <bold>1</bold>\u2013<bold>3</bold> transform to API\nunder acid conditions (see <ext-link xlink:href=\"http://pubs.acs.org/doi/suppl/10.1021/acs.cgd.5b01839/suppl_file/cg5b01839_si_001.pdf\">Figure S7</ext-link>) and\nthis transformation might lead to the decrease of solubility. The\nrapid dissolution behavior of <bold>1</bold>\u2013<bold>4</bold> would be beneficial to their gastrointestinal absorption. The solid\nforms of <bold>1</bold> and <bold>2</bold> were found to be stable\nunder ambient conditions (\u223c25 \u00b0C and 30% relative humidity)\nfor more than three months (see <ext-link xlink:href=\"http://pubs.acs.org/doi/suppl/10.1021/acs.cgd.5b01839/suppl_file/cg5b01839_si_001.pdf\">Supporting Information</ext-link> Figure S8). However, they are unstable under moisture conditions\n(40 \u00b0C and 75% relative humidity) as confirmed by PXRD results.</p>", "clean_text": "Dissolution Study and Stability\n\nPowder dissolution profiles of rebamipide API and compounds 1-4 in simulated succus gastricus (HCl solution with pH = 1.2) are shown in . It is found that both the dissolution rate and apparent solubilities of 1-4 are higher than those of API. All the compounds reach their maximum solubility (S max) within 17 min and S max is enhanced by 4.05, 4.73, 3.21, and 1.23 times for 1-4, respectively, compared to that of API (a). Then the solubilities of 1-3 began to decrease and after 36 h the solubility of each compound was close to that of API (b). Similar phenomena have been reported by Lu T. B. et al. The left solid samples of the dissolution experiments were collected and characterized by PXRD. The PXRD patterns display that compounds 1-3 transform to API under acid conditions (see Figure S7) and this transformation might lead to the decrease of solubility. The rapid dissolution behavior of 1-4 would be beneficial to their gastrointestinal absorption. The solid forms of 1 and 2 were found to be stable under ambient conditions (~25 \u00b0C and 30% relative humidity) for more than three months (see Supporting Information Figure S8). However, they are unstable under moisture conditions (40 \u00b0C and 75% relative humidity) as confirmed by PXRD results.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 40, "type": "figure", "classification": null, "content": "<fig id=\"fig9\" position=\"float\">\n<label>9</label>\n<caption>\n<p>Dissolution\nprofiles of API and compounds <bold>1</bold>\u2013<bold>4</bold> in HCl solution (pH = 1.2) within (a) 35 min and (b) 36\nh.</p>\n</caption>\n<graphic id=\"gr12\" position=\"float\" xlink:href=\"cg-2015-01839n_0010.tif\"></graphic>\n</fig>", "clean_text": " 9  Dissolution profiles of API and compounds 1-4 in HCl solution (pH = 1.2) within (a) 35 min and (b) 36 h.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 41, "type": "text", "classification": ["else"], "content": "<title>Pharmacokinetic Study</title><p>The pharmacokinetic study (PK)\nof compounds <bold>1</bold>\u2013<bold>4</bold> and original API\nwas carried out in Wistar rats, which is a classic model to evaluate\na drug\u2019s absorption. The mean plasma concentration vs time\nplots for rebamipide and compounds <bold>1</bold>\u2013<bold>4</bold> after oral administration are shown in . Three important PK parameters, maximal\nplasma concentration (<italic>C</italic>\n<sub>max</sub>), the time\nrequired to reach the <italic>C</italic>\n<sub>max</sub> (<italic>t</italic>\n<sub>max</sub>), and the area under the curve (AUC), are present\nin .</p>", "clean_text": "Pharmacokinetic Study\n\nThe pharmacokinetic study (PK) of compounds 1-4 and original API was carried out in Wistar rats, which is a classic model to evaluate a drug's absorption. The mean plasma concentration vs time plots for rebamipide and compounds 1-4 after oral administration are shown in . Three important PK parameters, maximal plasma concentration (C max), the time required to reach the C max (t max), and the area under the curve (AUC), are present in .", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 42, "type": "figure", "classification": null, "content": "<fig id=\"fig10\" position=\"float\">\n<label>10</label>\n<caption>\n<p>Mean plasma\nconcentration vs time profiles of original API and\ncompounds <bold>1</bold>\u2013<bold>4</bold> in rats after oral\nadministration.</p>\n</caption>\n<graphic id=\"gr13\" position=\"float\" xlink:href=\"cg-2015-01839n_0011.tif\"></graphic>\n</fig>", "clean_text": " 10  Mean plasma concentration vs time profiles of original API and compounds 1-4 in rats after oral administration.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 43, "type": "table", "classification": null, "content": "<table-wrap id=\"tbl3\" position=\"float\">\n<label>3</label>\n<caption>\n<title>PK Data\nof the Original API and Compounds <bold>1-4</bold>\n</title>\n</caption>\n<oasis:table colsep=\"0\" rowsep=\"0\">\n<oasis:tgroup cols=\"5\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col3\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col4\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col5\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\">drug</oasis:entry>\n<oasis:entry align=\"center\">\n<italic>C</italic>\n<sub>max</sub>(ng/mL)</oasis:entry>\n<oasis:entry align=\"center\">\n<italic>t</italic>\n<sub>max</sub>(h)</oasis:entry>\n<oasis:entry align=\"center\">AUC (ng\u00b7h/mL)</oasis:entry>\n<oasis:entry align=\"center\">\n<italic>F</italic> (%)</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>original API</oasis:entry>\n<oasis:entry>202.5</oasis:entry>\n<oasis:entry>3.00</oasis:entry>\n<oasis:entry>1694.0</oasis:entry>\n<oasis:entry>100.0</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>compound <bold>1</bold>\n</oasis:entry>\n<oasis:entry>239.3</oasis:entry>\n<oasis:entry>3.00</oasis:entry>\n<oasis:entry>2052.4</oasis:entry>\n<oasis:entry>121.2</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>compound <bold>2</bold>\n</oasis:entry>\n<oasis:entry>53.82</oasis:entry>\n<oasis:entry>0.50</oasis:entry>\n<oasis:entry>948.20</oasis:entry>\n<oasis:entry>56.00</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>compound <bold>3</bold>\n</oasis:entry>\n<oasis:entry>227.2</oasis:entry>\n<oasis:entry>6.00</oasis:entry>\n<oasis:entry>2348.5</oasis:entry>\n<oasis:entry>138.6</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>compound <bold>4</bold>\n</oasis:entry>\n<oasis:entry>355.0</oasis:entry>\n<oasis:entry>4.00</oasis:entry>\n<oasis:entry>3229.8</oasis:entry>\n<oasis:entry>190.7</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n</table-wrap>", "clean_text": "", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 44, "type": "text", "classification": "error", "content": "<p>In pharmacology, bioavailability\nis measured by the AUC value.\nTaking the AUC<sub>0\u2011\u221e</sub> of API as 100%, the relative bioavailability\nof <bold>1</bold>\u2013<bold>4</bold> was calculated as 121.2, 56.00,\n138.6, and 190.7%, respectively. The results indicate that the absorption\nof compounds <bold>1</bold>, <bold>3</bold>, or <bold>4</bold> upon\noral administration is better than that of API. In addition, <italic>C</italic>\n<sub>max</sub> value of <bold>4</bold> is increased by\n1.8-fold. Rebamipide as a class IV drug faces two problems: low solubility\nand low permeability. For <bold>4</bold>, although its solubility\nis nearly the same as that of API, its absorption is superior to others\nas the permeability of the drug is enhanced by forming ester. Moreover,\nthe in vivo experiments display that the methyl ester of rebamipide, <bold>4</bold>, rapidly and completely converts to the API because in the\nrange of 0.17 to 24 h no methyl ester compound is detected. For <bold>1</bold> and <bold>3</bold>, the improvement of bioavailability is\nprobably due to their good dissolution behavior. As for <bold>2</bold>, although its dissolution behavior is better than others, its absorption\nis poorer than others. We speculate that the poor absorption behavior\nof <bold>2</bold> might be relative to the formation of imidic acid\ntautomer (see ) and its low permeability after forming salt. The inconsistency of in vivo and in vitro experiments indicates\nthat the in vivo environment is rather complex and the dissolution\nstudy is insufficient to accurately evaluate the absorption of a drug.</p>", "clean_text": "In pharmacology, bioavailability is measured by the AUC value. Taking the AUC0-\u221e of API as 100%, the relative bioavailability of 1-4 was calculated as 121.2, 56.00, 138.6, and 190.7%, respectively. The results indicate that the absorption of compounds 1, 3, or 4 upon oral administration is better than that of API. In addition, C max value of 4 is increased by 1.8-fold. Rebamipide as a class IV drug faces two problems: low solubility and low permeability. For 4, although its solubility is nearly the same as that of API, its absorption is superior to others as the permeability of the drug is enhanced by forming ester. Moreover, the in vivo experiments display that the methyl ester of rebamipide, 4, rapidly and completely converts to the API because in the range of 0.17 to 24 h no methyl ester compound is detected. For 1 and 3, the improvement of bioavailability is probably due to their good dissolution behavior. As for 2, although its dissolution behavior is better than others, its absorption is poorer than others. We speculate that the poor absorption behavior of 2 might be relative to the formation of imidic acid tautomer (see ) and its low permeability after forming salt. The inconsistency of in vivo and in vitro experiments indicates that the in vivo environment is rather complex and the dissolution study is insufficient to accurately evaluate the absorption of a drug.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 45, "type": "text", "classification": ["else"], "content": "<title>Conclusions</title><p>In this work, two sodium salts <bold>1</bold> and <bold>2</bold>, one solvate <bold>3</bold>, and methyl ester <bold>4</bold> of\nrebamipide have been synthesized and for the first time the crystal\nstructures of this drug have been determined. The control experiments\ndisplay that the controlling factor in the preparation of <bold>1</bold> and <bold>2</bold> is reaction temperature and the one in the synthesis\nof <bold>3</bold> and <bold>4</bold> is solubility of product. It\nis notable that the solubility and oral bioavailability of <bold>1</bold>, <bold>3</bold>, and <bold>4</bold> have been obviously improved,\nrelative to those of API. Therefore, the three compounds could be\npotential candidates in the pharmaceutical industry. In addition,\ntoxicity and efficacy studies continue in our laboratory.</p>", "clean_text": "Conclusions\n\nIn this work, two sodium salts 1 and 2, one solvate 3, and methyl ester 4 of rebamipide have been synthesized and for the first time the crystal structures of this drug have been determined. The control experiments display that the controlling factor in the preparation of 1 and 2 is reaction temperature and the one in the synthesis of 3 and 4 is solubility of product. It is notable that the solubility and oral bioavailability of 1, 3, and 4 have been obviously improved, relative to those of API. Therefore, the three compounds could be potential candidates in the pharmaceutical industry. In addition, toxicity and efficacy studies continue in our laboratory.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 46, "type": "text", "classification": ["else"], "content": "<p>The Supporting\nInformation\nis available free of charge on the <ext-link xlink:href=\"http://pubs.acs.org\">ACS Publications website</ext-link> at DOI: <ext-link xlink:href=\"http://pubs.acs.org/doi/abs/10.1021/acs.cgd.5b01839\">10.1021/acs.cgd.5b01839</ext-link>.<list id=\"silist\" list-type=\"label\">\n<list-item>\n<p>Additional measured\nand calculated PXRD patterns, IR\nspectra, <sup>1</sup>H NMR spectra, MS spectra, and the selected bond\ndistances and angles (<ext-link xlink:href=\"http://pubs.acs.org/doi/suppl/10.1021/acs.cgd.5b01839/suppl_file/cg5b01839_si_001.pdf\">PDF</ext-link>)</p>\n</list-item>\n</list>\n</p>", "clean_text": "The Supporting Information is available free of charge on the ACS Publications website at DOI: 10.1021/acs.cgd.5b01839.  Additional measured and calculated PXRD patterns, IR spectra, 1H NMR spectra, MS spectra, and the selected bond distances and angles (PDF)   ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 47, "type": "text", "classification": ["else"], "content": "<p>Additional measured\nand calculated PXRD patterns, IR\nspectra, <sup>1</sup>H NMR spectra, MS spectra, and the selected bond\ndistances and angles (<ext-link xlink:href=\"http://pubs.acs.org/doi/suppl/10.1021/acs.cgd.5b01839/suppl_file/cg5b01839_si_001.pdf\">PDF</ext-link>)</p><p>CCDC <ext-link ext-link-type=\"ccdc\" xlink:href=\"1404894\">1404894</ext-link>, <ext-link ext-link-type=\"ccdc\" xlink:href=\"1404896\">1404896</ext-link>, <ext-link ext-link-type=\"ccdc\" xlink:href=\"1439500\">1439500</ext-link>, and <ext-link ext-link-type=\"ccdc\" xlink:href=\"1439505\">1439505</ext-link> contain the supplementary crystallographic data\nfor this paper. These data can be obtained free of charge via <ext-link xlink:href=\"http://www.ccdc.cam.ac.uk/data_request/cif\">www.ccdc.cam.ac.uk/data_request/cif</ext-link>, or by emailing <email>data_request@ccdc.cam.ac.uk</email>, or by\ncontacting The Cambridge Crystallographic Data Centre, 12, Union Road,\nCambridge CB2 1EZ, UK; fax: +44 1223 336033.</p>", "clean_text": "Additional measured and calculated PXRD patterns, IR spectra, 1H NMR spectra, MS spectra, and the selected bond distances and angles (PDF)\n\nCCDC 1404894, 1404896, 1439500, and 1439505 contain the supplementary crystallographic data for this paper. These data can be obtained free of charge via www.ccdc.cam.ac.uk/data_request/cif, or by emailing data_request@ccdc.cam.ac.uk, or by contacting The Cambridge Crystallographic Data Centre, 12, Union Road, Cambridge CB2 1EZ, UK; fax: +44 1223 336033.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 48, "type": "text", "classification": ["else"], "content": "<p>Y.C. and\nC.L. contributed equally to this work.</p><p>The authors declare no\ncompeting financial interest.</p><title>References</title>", "clean_text": "Y.C. and C.L. contributed equally to this work.\n\nThe authors declare no competing financial interest.\n\nReferences", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}], "cln_elements": [{"idx": "8, 9, 10, 11", "type": "text", "classification": "synthesis condition", "content": "<title>Synthesis of Na\u00ad(CH<sub>3</sub>CH<sub>2</sub>OH) (HReb) (<bold>1</bold>)</title><p>Rebamipide\n(100 mg, 0.27 mmol) was dissolved in\n15 mL ethanol and then stirred for 2 h. To this was added 0.075 mL\nNaOH (5 M) with vigorously stirring. The resulting solution was filtered\nand allowed for slow evaporation under ambient conditions. Colorless\nblock single crystals of <bold>1</bold> suitable for single X-ray\ndiffraction were obtained and dried under ambient conditions (yield\nof 95 mg, \u223c80% based on rebamipide).</p><title>Synthesis of Na<sub>2</sub>(H<sub>2</sub>O)<sub>4</sub>(Reb)\n(<bold>2</bold>)</title><p>Compound <bold>2</bold> was prepared using\na procedure similar to that for <bold>1</bold>. The only difference\nis that the mixture of rebamipide and sodium hydroxide solution was\nheated at 50 \u00b0C for 30 min, then filtered and allowed for crystallization.\nAfter 1 day, colorless needle-like single crystals of <bold>2</bold> were isolated and dried at ambient conditions (yield of 98 mg, \u223c75%\nbased on rebamipide).</p><title>Synthesis of H<sub>2</sub>Reb\u00b7CH<sub>3</sub>OH (<bold>3</bold>)</title><p>Rebamipide (45 mg, 0.12 mmol)\nwas dissolved in 15 mL methanol\nand stirred for 2 h. The solution was then transferred to a Teflon-lined\nautoclave (15 mL) and kept at 120 \u00b0C for 48 h. After the mixture\nwas slowly cooled to room temperature, the resulting solution was\nfiltered and slowly evaporated at ambient conditions. After 2 days,\ncolorless needle-shaped crystals of <bold>3</bold> were harvested\n(yield of 40 mg, \u223c82% based on rebamipide) and one single crystal\nwas chosen for X-ray analysis.</p><title>Synthesis of Rebamipide\nMethyl Ester (<bold>4</bold>)</title><p>Compound <bold>4</bold> was\nsynthesized using a procedure similar\nto that of <bold>3</bold>. The only difference is that the API was\ndissolved in the methanol-H<sub>2</sub>O (v:v = 3:1) solution. The\nobtained solution was heated at 120 \u00b0C in a Teflon-lined autoclave\n(15 mL) for 48 h, and then the resulting solution was allowed to evaporate\nat ambient conditions. Colorless block crystals of <bold>4</bold> were\nisolated after about 7 days (yield 35 mg, \u223c75% based on rebamipide). <sup>1</sup>H NMR (DMSO-<italic>d</italic>\n<sub>6</sub>, 400 MHz) \u03b4\n(ppm) 11.66 (1H, s, imino group), 9.03 (1H, d, imino group), 7.21\u20137.85\n(8H, m, phenyl), 6.44 (1H, s, alkenyl), 4.35 (1H, t, methine), 3.69\n(3H, s, methyl), 2.06 (2H, s, methylene). (<ext-link xlink:href=\"http://pubs.acs.org/doi/suppl/10.1021/acs.cgd.5b01839/suppl_file/cg5b01839_si_001.pdf\">Supporting Information</ext-link>, Figure S1)</p>", "clean_text": "Synthesis of Na(CH3CH2OH) (HReb) (1)\n\nRebamipide (100 mg, 0.27 mmol) was dissolved in 15 mL ethanol and then stirred for 2 h. To this was added 0.075 mL NaOH (5 M) with vigorously stirring. The resulting solution was filtered and allowed for slow evaporation under ambient conditions. Colorless block single crystals of 1 suitable for single X-ray diffraction were obtained and dried under ambient conditions (yield of 95 mg, ~80% based on rebamipide).\n\nSynthesis of Na2(H2O)4(Reb) (2)\n\nCompound 2 was prepared using a procedure similar to that for 1. The only difference is that the mixture of rebamipide and sodium hydroxide solution was heated at 50 \u00b0C for 30 min, then filtered and allowed for crystallization. After 1 day, colorless needle-like single crystals of 2 were isolated and dried at ambient conditions (yield of 98 mg, ~75% based on rebamipide).\n\nSynthesis of H2Reb\u22c5CH3OH (3)\n\nRebamipide (45 mg, 0.12 mmol) was dissolved in 15 mL methanol and stirred for 2 h. The solution was then transferred to a Teflon-lined autoclave (15 mL) and kept at 120 \u00b0C for 48 h. After the mixture was slowly cooled to room temperature, the resulting solution was filtered and slowly evaporated at ambient conditions. After 2 days, colorless needle-shaped crystals of 3 were harvested (yield of 40 mg, ~82% based on rebamipide) and one single crystal was chosen for X-ray analysis.\n\nSynthesis of Rebamipide Methyl Ester (4)\n\nCompound 4 was synthesized using a procedure similar to that of 3. The only difference is that the API was dissolved in the methanol-H2O (v:v = 3:1) solution. The obtained solution was heated at 120 \u00b0C in a Teflon-lined autoclave (15 mL) for 48 h, and then the resulting solution was allowed to evaporate at ambient conditions. Colorless block crystals of 4 were isolated after about 7 days (yield 35 mg, ~75% based on rebamipide). 1H NMR (DMSO-d 6, 400 MHz) \u03b4 (ppm) 11.66 (1H, s, imino group), 9.03 (1H, d, imino group), 7.21-7.85 (8H, m, phenyl), 6.44 (1H, s, alkenyl), 4.35 (1H, t, methine), 3.69 (3H, s, methyl), 2.06 (2H, s, methylene). (Supporting Information, Figure S1)", "data": [[{"meta": {"name": "Na(CH3CH2OH)(HReb)", "symbol": "1", "chemical formula": ""}, "processes": [{"synthesis method": "chemical synthesis", "precursor": [{"name": "Rebamipide", "amount": "100", "unit": "mg"}], "solution": [{"name": "ethanol", "amount": "15", "unit": "mL"}], "pressure": "", "temperature": "", "time": "2 h"}, {"synthesis method": "chemical synthesis", "precursor": [{"name": "NaOH", "amount": "0.075", "unit": "mL"}], "solution": [{"name": "5 M", "amount": "", "unit": ""}], "pressure": "", "temperature": "", "time": ""}, {"synthesis method": "filtration", "time": "", "atmosphere": "", "pressure": ""}, {"synthesis method": "drying", "pressure": "", "temperature": "ambient conditions", "atmosphere": "", "time": ""}], "yield": "~80%", "other properties": []}, {"meta": {"name": "Na2(H2O)4(Reb)", "symbol": "2", "chemical formula": ""}, "processes": [{"synthesis method": "chemical synthesis", "precursor": [{"name": "Rebamipide", "amount": "100", "unit": "mg"}, {"name": "NaOH", "amount": "0.075", "unit": "mL"}], "solution": [{"name": "5 M", "amount": "", "unit": ""}], "pressure": "", "temperature": "50 \u00b0C", "time": "30 min"}, {"synthesis method": "filtration", "time": "", "atmosphere": "", "pressure": ""}, {"synthesis method": "drying", "pressure": "", "temperature": "ambient conditions", "atmosphere": "", "time": ""}], "yield": "~75%", "other properties": []}, {"meta": {"name": "H2Reb\u22c5CH3OH", "symbol": "3", "chemical formula": ""}, "processes": [{"synthesis method": "chemical synthesis", "precursor": [{"name": "Rebamipide", "amount": "45", "unit": "mg"}], "solution": [{"name": "methanol", "amount": "15", "unit": "mL"}], "pressure": "", "temperature": "", "time": "2 h"}, {"synthesis method": "solvothermal synthesis", "precursor": [], "solvent": [], "reducing agent": [], "surfactant": [], "pressure": "", "temperature": "120 \u00b0C", "time": "48 h", "heating rate": "", "cooling rate": ""}, {"synthesis method": "filtration", "time": "", "atmosphere": "", "pressure": ""}, {"synthesis method": "drying", "pressure": "", "temperature": "ambient conditions", "atmosphere": "", "time": ""}], "yield": "~82%", "other properties": []}, {"meta": {"name": "Rebamipide Methyl Ester", "symbol": "4", "chemical formula": ""}, "processes": [{"synthesis method": "chemical synthesis", "precursor": [{"name": "Rebamipide", "amount": "45", "unit": "mg"}], "solution": [{"name": "methanol-H2O", "amount": "3:1 v:v", "unit": ""}], "pressure": "", "temperature": "120 \u00b0C", "time": "48 h"}, {"synthesis method": "solvothermal synthesis", "precursor": [], "solvent": [], "reducing agent": [], "surfactant": [], "pressure": "", "temperature": "", "time": "", "heating rate": "", "cooling rate": ""}, {"synthesis method": "drying", "pressure": "", "temperature": "ambient conditions", "atmosphere": "", "time": ""}], "yield": "~75%", "other properties": ["1H NMR (DMSO-d6, 400 MHz) \u03b4 (ppm) 11.66 (1H, s, imino group), 9.03 (1H, d, imino group), 7.21-7.85 (8H, m, phenyl), 6.44 (1H, s, alkenyl), 4.35 (1H, t, methine), 3.69 (3H, s, methyl), 2.06 (2H, s, methylene)"]}]], "include_properties": ["drying", "filtration", "chemical_synthesis"], "intermediate_step": {"text-synthesis-type": "['chemical_synthesis', 'filtration', 'drying']", "text-synthesis-struct": "```JSON\n[\n    {\n        \"meta\": {\n            \"name\": \"Na(CH3CH2OH)(HReb)\",\n            \"symbol\": \"1\",\n            \"chemical formula\": \"\"\n        },\n        \"processes\": [\n            {\n                \"synthesis method\": \"chemical synthesis\",\n                \"precursor\": [\n                    {\n                        \"name\": \"Rebamipide\",\n                        \"amount\": \"100\",\n                        \"unit\": \"mg\"\n                    }\n                ],\n                \"solution\": [\n                    {\n                        \"name\": \"ethanol\",\n                        \"amount\": \"15\",\n                        \"unit\": \"mL\"\n                    }\n                ],\n                \"pressure\": \"\",\n                \"temperature\": \"\",\n                \"time\": \"2 h\"\n            },\n            {\n                \"synthesis method\": \"chemical synthesis\",\n                \"precursor\": [\n                    {\n                        \"name\": \"NaOH\",\n                        \"amount\": \"0.075\",\n                        \"unit\": \"mL\"\n                    }\n                ],\n                \"solution\": [\n                    {\n                        \"name\": \"5 M\",\n                        \"amount\": \"\",\n                        \"unit\": \"\"\n                    }\n                ],\n                \"pressure\": \"\",\n                \"temperature\": \"\",\n                \"time\": \"\"\n            },\n            {\n                \"synthesis method\": \"filtration\",\n                \"time\": \"\",\n                \"atmosphere\": \"\",\n                \"pressure\": \"\"\n            },\n            {\n                \"synthesis method\": \"drying\",\n                \"pressure\": \"\",\n                \"temperature\": \"ambient conditions\",\n                \"atmosphere\": \"\",\n                \"time\": \"\"\n            }\n        ],\n        \"yield\": \"~80%\",\n        \"other properties\": []\n    },\n    {\n        \"meta\": {\n            \"name\": \"Na2(H2O)4(Reb)\",\n            \"symbol\": \"2\",\n            \"chemical formula\": \"\"\n        },\n        \"processes\": [\n            {\n                \"synthesis method\": \"chemical synthesis\",\n                \"precursor\": [\n                    {\n                        \"name\": \"Rebamipide\",\n                        \"amount\": \"100\",\n                        \"unit\": \"mg\"\n                    },\n                    {\n                        \"name\": \"NaOH\",\n                        \"amount\": \"0.075\",\n                        \"unit\": \"mL\"\n                    }\n                ],\n                \"solution\": [\n                    {\n                        \"name\": \"5 M\",\n                        \"amount\": \"\",\n                        \"unit\": \"\"\n                    }\n                ],\n                \"pressure\": \"\",\n                \"temperature\": \"50 \u00b0C\",\n                \"time\": \"30 min\"\n            },\n            {\n                \"synthesis method\": \"filtration\",\n                \"time\": \"\",\n                \"atmosphere\": \"\",\n                \"pressure\": \"\"\n            },\n            {\n                \"synthesis method\": \"drying\",\n                \"pressure\": \"\",\n                \"temperature\": \"ambient conditions\",\n                \"atmosphere\": \"\",\n                \"time\": \"\"\n            }\n        ],\n        \"yield\": \"~75%\",\n        \"other properties\": []\n    },\n    {\n        \"meta\": {\n            \"name\": \"H2Reb\u22c5CH3OH\",\n            \"symbol\": \"3\",\n            \"chemical formula\": \"\"\n        },\n        \"processes\": [\n            {\n                \"synthesis method\": \"chemical synthesis\",\n                \"precursor\": [\n                    {\n                        \"name\": \"Rebamipide\",\n                        \"amount\": \"45\",\n                        \"unit\": \"mg\"\n                    }\n                ],\n                \"solution\": [\n                    {\n                        \"name\": \"methanol\",\n                        \"amount\": \"15\",\n                        \"unit\": \"mL\"\n                    }\n                ],\n                \"pressure\": \"\",\n                \"temperature\": \"\",\n                \"time\": \"2 h\"\n            },\n            {\n                \"synthesis method\": \"solvothermal synthesis\",\n                \"precursor\": [],\n                \"solvent\": [],\n                \"reducing agent\": [],\n                \"surfactant\": [],\n                \"pressure\": \"\",\n                \"temperature\": \"120 \u00b0C\",\n                \"time\": \"48 h\",\n                \"heating rate\": \"\",\n                \"cooling rate\": \"\"\n            },\n            {\n                \"synthesis method\": \"filtration\",\n                \"time\": \"\",\n                \"atmosphere\": \"\",\n                \"pressure\": \"\"\n            },\n            {\n                \"synthesis method\": \"drying\",\n                \"pressure\": \"\",\n                \"temperature\": \"ambient conditions\",\n                \"atmosphere\": \"\",\n                \"time\": \"\"\n            }\n        ],\n        \"yield\": \"~82%\",\n        \"other properties\": []\n    },\n    {\n        \"meta\": {\n            \"name\": \"Rebamipide Methyl Ester\",\n            \"symbol\": \"4\",\n            \"chemical formula\": \"\"\n        },\n        \"processes\": [\n            {\n                \"synthesis method\": \"chemical synthesis\",\n                \"precursor\": [\n                    {\n                        \"name\": \"Rebamipide\",\n                        \"amount\": \"45\",\n                        \"unit\": \"mg\"\n                    }\n                ],\n                \"solution\": [\n                    {\n                        \"name\": \"methanol-H2O\",\n                        \"amount\": \"3:1 v:v\",\n                        \"unit\": \"\"\n                    }\n                ],\n                \"pressure\": \"\",\n                \"temperature\": \"120 \u00b0C\",\n                \"time\": \"48 h\"\n            },\n            {\n                \"synthesis method\": \"solvothermal synthesis\",\n                \"precursor\": [],\n                \"solvent\": [],\n                \"reducing agent\": [],\n                \"surfactant\": [],\n                \"pressure\": \"\",\n                \"temperature\": \"\",\n                \"time\": \"\",\n                \"heating rate\": \"\",\n                \"cooling rate\": \"\"\n            },\n            {\n                \"synthesis method\": \"drying\",\n                \"pressure\": \"\",\n                \"temperature\": \"ambient conditions\",\n                \"atmosphere\": \"\",\n                \"time\": \"\"\n            }\n        ],\n        \"yield\": \"~75%\",\n        \"other properties\": [\n            \"1H NMR (DMSO-d6, 400 MHz) \u03b4 (ppm) 11.66 (1H, s, imino group), 9.03 (1H, d, imino group), 7.21-7.85 (8H, m, phenyl), 6.44 (1H, s, alkenyl), 4.35 (1H, t, methine), 3.69 (3H, s, methyl), 2.06 (2H, s, methylene)\"\n        ]\n    }\n]\n```"}}, {"idx": 36, "type": "text", "classification": "property", "content": "<p>The thermal behaviors of API and compounds <bold>1</bold>\u2013<bold>4</bold> were investigated by differential scanning\ncalorimetry (DSC)\nand thermogravimetric analysis (TGA). The results are presented in . In the DSC and\nTGA plots of <bold>1</bold>, an initial endotherm at 160 \u00b0C corresponds\nto a weight loss of ethanol molecule (obsd.10.40%, calc.10.49%), and\nthe endotherm at 318 \u00b0C is attributed to the decomposition of <bold>1</bold>. For <bold>2</bold>, the TGA curve shows a weight loss of\n14.70% in the 73\u201397 \u00b0C range, which is consistent with\nthe loss of four water molecules (calc.14.79%). Then upon further\nheating, compound <bold>2</bold> decomposes at 267 \u00b0C. The first\nendothermic peak of <bold>3</bold> at 151 \u00b0C is for the loss\nof methanol molecular (obsd.7.98%, calc.7.95%) and <bold>3</bold> decomposes\nat 273 \u00b0C. The melting point of <bold>4</bold> is 269 \u00b0C\nand above this decomposition begins.</p>", "clean_text": "The thermal behaviors of API and compounds 1-4 were investigated by differential scanning calorimetry (DSC) and thermogravimetric analysis (TGA). The results are presented in . In the DSC and TGA plots of 1, an initial endotherm at 160 \u00b0C corresponds to a weight loss of ethanol molecule (obsd.10.40%, calc.10.49%), and the endotherm at 318 \u00b0C is attributed to the decomposition of 1. For 2, the TGA curve shows a weight loss of 14.70% in the 73-97 \u00b0C range, which is consistent with the loss of four water molecules (calc.14.79%). Then upon further heating, compound 2 decomposes at 267 \u00b0C. The first endothermic peak of 3 at 151 \u00b0C is for the loss of methanol molecular (obsd.7.98%, calc.7.95%) and 3 decomposes at 273 \u00b0C. The melting point of 4 is 269 \u00b0C and above this decomposition begins.", "data": [[[{"meta": {"name": "API", "symbol": "", "chemical formula": ""}, "decomposition temperature": []}, {"meta": {"name": "", "symbol": "1", "chemical formula": ""}, "decomposition temperature": [{"value": "160", "unit": "\u00b0C", "type": "weight loss of ethanol molecule", "condition": ""}, {"value": "318", "unit": "\u00b0C", "type": "decomposition point", "condition": ""}]}, {"meta": {"name": "", "symbol": "2", "chemical formula": ""}, "decomposition temperature": [{"value": "73 to 97", "unit": "\u00b0C", "type": "weight loss of water molecules", "condition": ""}, {"value": "267", "unit": "\u00b0C", "type": "decomposition point", "condition": ""}]}, {"meta": {"name": "", "symbol": "3", "chemical formula": ""}, "decomposition temperature": [{"value": "151", "unit": "\u00b0C", "type": "weight loss of methanol molecule", "condition": ""}, {"value": "273", "unit": "\u00b0C", "type": "decomposition point", "condition": ""}]}, {"meta": {"name": "", "symbol": "4", "chemical formula": ""}, "decomposition temperature": [{"value": "269", "unit": "\u00b0C", "type": "decomposition point", "condition": "above melting point"}]}]]], "include_properties": ["decomposition_temperature"], "intermediate_step": {"categorize": "['property']", "text-property-type": "['decomposition_temperature']", "text-property-extract": "```JSON\n[\n    {\n        \"meta\": {\n            \"name\": \"API\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"\"\n        },\n        \"decomposition temperature\": []\n    },\n    {\n        \"meta\": {\n            \"name\": \"\",\n            \"symbol\": \"1\",\n            \"chemical formula\": \"\"\n        },\n        \"decomposition temperature\": [\n            {\n                \"value\": \"160\",\n                \"unit\": \"\u00b0C\",\n                \"type\": \"weight loss of ethanol molecule\",\n                \"condition\": \"\"\n            },\n            {\n                \"value\": \"318\",\n                \"unit\": \"\u00b0C\",\n                \"type\": \"decomposition point\",\n                \"condition\": \"\"\n            }\n        ]\n    },\n    {\n        \"meta\": {\n            \"name\": \"\",\n            \"symbol\": \"2\",\n            \"chemical formula\": \"\"\n        },\n        \"decomposition temperature\": [\n            {\n                \"value\": \"73 to 97\",\n                \"unit\": \"\u00b0C\",\n                \"type\": \"weight loss of water molecules\",\n                \"condition\": \"\"\n            },\n            {\n                \"value\": \"267\",\n                \"unit\": \"\u00b0C\",\n                \"type\": \"decomposition point\",\n                \"condition\": \"\"\n            }\n        ]\n    },\n    {\n        \"meta\": {\n            \"name\": \"\",\n            \"symbol\": \"3\",\n            \"chemical formula\": \"\"\n        },\n        \"decomposition temperature\": [\n            {\n                \"value\": \"151\",\n                \"unit\": \"\u00b0C\",\n                \"type\": \"weight loss of methanol molecule\",\n                \"condition\": \"\"\n            },\n            {\n                \"value\": \"273\",\n                \"unit\": \"\u00b0C\",\n                \"type\": \"decomposition point\",\n                \"condition\": \"\"\n            }\n        ]\n    },\n    {\n        \"meta\": {\n            \"name\": \"\",\n            \"symbol\": \"4\",\n            \"chemical formula\": \"\"\n        },\n        \"decomposition temperature\": [\n            {\n                \"value\": \"269\",\n                \"unit\": \"\u00b0C\",\n                \"type\": \"decomposition point\",\n                \"condition\": \"above melting point\"\n            }\n        ]\n    }\n]\n```"}}, {"idx": 13, "type": "table", "classification": ["Crystal"], "content": "<table-wrap id=\"tbl1\" position=\"float\">\n<label>1</label>\n<caption>\n<title>Crystallographic Data for Compounds <bold>1</bold>\u2013<bold>4</bold>\n<xref rid=\"t1fn1\"></xref>\n</title>\n</caption>\n<oasis:table colsep=\"0\" rowsep=\"0\">\n<oasis:tgroup cols=\"5\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col3\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col4\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col5\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\"></oasis:entry>\n<oasis:entry align=\"center\">1</oasis:entry>\n<oasis:entry align=\"center\">2</oasis:entry>\n<oasis:entry align=\"center\">3</oasis:entry>\n<oasis:entry align=\"center\">4</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>formula</oasis:entry>\n<oasis:entry>C<sub>21</sub>H<sub>20</sub>ClN<sub>2</sub>NaO<sub>5</sub>\n</oasis:entry>\n<oasis:entry>C<sub>19</sub>H<sub>21</sub>ClN<sub>2</sub>Na<sub>2</sub>O<sub>8</sub>\n</oasis:entry>\n<oasis:entry>C<sub>20</sub>H<sub>19</sub>ClN<sub>2</sub>O<sub>5</sub>\n</oasis:entry>\n<oasis:entry>C<sub>20</sub>H<sub>17</sub>ClN<sub>2</sub>O<sub>4</sub>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>formula weight</oasis:entry>\n<oasis:entry>438.83</oasis:entry>\n<oasis:entry>486.81</oasis:entry>\n<oasis:entry>402.82</oasis:entry>\n<oasis:entry>384.81</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>crystal\nsystem</oasis:entry>\n<oasis:entry>monoclinic</oasis:entry>\n<oasis:entry>orthorhombic</oasis:entry>\n<oasis:entry>monoclinic</oasis:entry>\n<oasis:entry>monoclinic</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>space group</oasis:entry>\n<oasis:entry>\n<italic>P</italic>21/<italic>c</italic>\n</oasis:entry>\n<oasis:entry>\n<italic>Pna</italic>2(1)</oasis:entry>\n<oasis:entry>\n<italic>C</italic>2/<italic>c</italic>\n</oasis:entry>\n<oasis:entry>\n<italic>P</italic>21<italic>c</italic>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>a</italic> (\u00c5)</oasis:entry>\n<oasis:entry>6.014(2)</oasis:entry>\n<oasis:entry>34.551(3)</oasis:entry>\n<oasis:entry>23.030(2)</oasis:entry>\n<oasis:entry>19.7573(15)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>b</italic> (\u00c5)</oasis:entry>\n<oasis:entry>23.279(9)</oasis:entry>\n<oasis:entry>5.0944(4)</oasis:entry>\n<oasis:entry>19.1331(18)</oasis:entry>\n<oasis:entry>5.0379(3)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>c</italic> (\u00c5)</oasis:entry>\n<oasis:entry>15.076(6)</oasis:entry>\n<oasis:entry>12.0785(11)</oasis:entry>\n<oasis:entry>9.6060(9)</oasis:entry>\n<oasis:entry>19.5600(12)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b1 (deg)</oasis:entry>\n<oasis:entry>90</oasis:entry>\n<oasis:entry>90</oasis:entry>\n<oasis:entry>90</oasis:entry>\n<oasis:entry>90</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b2\n(deg)</oasis:entry>\n<oasis:entry>99.969(7)</oasis:entry>\n<oasis:entry>90</oasis:entry>\n<oasis:entry>106.358(2)</oasis:entry>\n<oasis:entry>109.887(7)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b3 (deg)</oasis:entry>\n<oasis:entry>90</oasis:entry>\n<oasis:entry>90</oasis:entry>\n<oasis:entry>90</oasis:entry>\n<oasis:entry>90</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>Z</italic>\n</oasis:entry>\n<oasis:entry>4</oasis:entry>\n<oasis:entry>4</oasis:entry>\n<oasis:entry>8</oasis:entry>\n<oasis:entry>4</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>volume (\u00c5<sup>3</sup>)</oasis:entry>\n<oasis:entry>2078.9(14)</oasis:entry>\n<oasis:entry>2126.0(3)</oasis:entry>\n<oasis:entry>4061.4(7)</oasis:entry>\n<oasis:entry>1830.8(2)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>D</italic>\n<sub>calc</sub> (g\u00b7cm<sup>\u20133</sup>)</oasis:entry>\n<oasis:entry>1.402</oasis:entry>\n<oasis:entry>1.521</oasis:entry>\n<oasis:entry>1.318</oasis:entry>\n<oasis:entry>1.396</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>F</italic> (000)</oasis:entry>\n<oasis:entry>912</oasis:entry>\n<oasis:entry>1008</oasis:entry>\n<oasis:entry>1680</oasis:entry>\n<oasis:entry>800</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>refns. collected</oasis:entry>\n<oasis:entry>10139</oasis:entry>\n<oasis:entry>9761</oasis:entry>\n<oasis:entry>10191</oasis:entry>\n<oasis:entry>8493</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>unique reflns.</oasis:entry>\n<oasis:entry>3637</oasis:entry>\n<oasis:entry>2869</oasis:entry>\n<oasis:entry>3572</oasis:entry>\n<oasis:entry>3382</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>R</italic>\n<sub>int</sub>\n</oasis:entry>\n<oasis:entry>0.0447</oasis:entry>\n<oasis:entry>0.0708</oasis:entry>\n<oasis:entry>0.0599</oasis:entry>\n<oasis:entry>0.0258</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>R</italic>\n<sub>1</sub>[<italic>I</italic>\u00a0&gt;\u00a02\u03c3(<italic>I</italic>)]</oasis:entry>\n<oasis:entry>0.0634</oasis:entry>\n<oasis:entry>0.0470</oasis:entry>\n<oasis:entry>0.0612</oasis:entry>\n<oasis:entry>0.0651</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>wR</italic>\n<sub>2</sub>[<italic>I</italic>\u00a0&gt;\u00a02\u03c3(<italic>I</italic>)]</oasis:entry>\n<oasis:entry>0.2021</oasis:entry>\n<oasis:entry>0.1020</oasis:entry>\n<oasis:entry>0.1437</oasis:entry>\n<oasis:entry>0.1702</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>R</italic>\n<sub>1</sub>(all data)</oasis:entry>\n<oasis:entry>0.1092</oasis:entry>\n<oasis:entry>0.0581</oasis:entry>\n<oasis:entry>0.1261</oasis:entry>\n<oasis:entry>0.0898</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>wR</italic>\n<sub>2</sub> (all data)</oasis:entry>\n<oasis:entry>0.2620</oasis:entry>\n<oasis:entry>0.1056</oasis:entry>\n<oasis:entry>0.1618</oasis:entry>\n<oasis:entry>0.1877</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>GOF on <italic>F</italic>\n<sup>2</sup>\n</oasis:entry>\n<oasis:entry>1.052</oasis:entry>\n<oasis:entry>1.060</oasis:entry>\n<oasis:entry>1.044</oasis:entry>\n<oasis:entry>1.065</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n<table-wrap-foot>\n<fn id=\"t1fn1\">\n<label>a</label>\n<p>\n<italic>R</italic>\n<sub>1</sub> =\n\u2211| |<italic>F</italic>\n<sub>o</sub>| \u2013 |<italic>F</italic>\n<sub>c</sub>| |/\u2211|<italic>F</italic>\n<sub>o</sub>|; <italic>wR</italic>\n<sub>2</sub> = \u2211[<italic>w</italic>(<italic>F</italic>\n<sub>o</sub>\n<sup>2</sup> \u2013 <italic>F</italic>\n<sub>c</sub>\n<sup>2</sup>)<sup>2</sup>]/\u2211[<italic>w</italic>(<italic>F</italic>\n<sub>o</sub>\n<sup>2</sup>)<sup>2</sup>]<sup>1/2</sup>\n</p>\n</fn>\n</table-wrap-foot>\n</table-wrap>", "clean_text": "Table 1. Crystallographic Data for Compounds 1\u20134[^a]\n\n|                    | 1                                      | 2                                      | 3                                      | 4                                      |\n|--------------------|----------------------------------------|----------------------------------------|----------------------------------------|----------------------------------------|\n| formula            | C<sub>21</sub>H<sub>20</sub>ClN<sub>2</sub>NaO<sub>5</sub> | C<sub>19</sub>H<sub>21</sub>ClN<sub>2</sub>Na<sub>2</sub>O<sub>8</sub> | C<sub>20</sub>H<sub>19</sub>ClN<sub>2</sub>O<sub>5</sub> | C<sub>20</sub>H<sub>17</sub>ClN<sub>2</sub>O<sub>4</sub> |\n| formula weight     | 438.83                                 | 486.81                                 | 402.82                                 | 384.81                                 |\n| crystal system     | monoclinic                             | orthorhombic                           | monoclinic                             | monoclinic                             |\n| space group        | P21/c                                  | Pna2(1)                                 | C2/c                                   | P21c                                   |\n| a (\u00c5)               | 6.014(2)                               | 34.551(3)                              | 23.030(2)                              | 19.7573(15)                            |\n| b (\u00c5)               | 23.279(9)                              | 5.0944(4)                              | 19.1331(18)                            | 5.0379(3)                              |\n| c (\u00c5)               | 15.076(6)                              | 12.0785(11)                            | 9.6060(9)                              | 19.5600(12)                            |\n| \u03b1 (deg)             | 90                                     | 90                                     | 90                                     | 90                                     |\n| \u03b2 (deg)             | 99.969(7)                              | 90                                     | 106.358(2)                             | 109.887(7)                             |\n| \u03b3 (deg)             | 90                                     | 90                                     | 90                                     | 90                                     |\n| Z                   | 4                                      | 4                                      | 8                                      | 4                                      |\n| volume (\u00c5<sup>3</sup>) | 2078.9(14)                           | 2126.0(3)                              | 4061.4(7)                              | 1830.8(2)                              |\n| D<sub>calc</sub> (g\u00b7cm<sup>\u20133</sup>) | 1.402                        | 1.521                                  | 1.318                                  | 1.396                                  |\n| F (000)             | 912                                    | 1008                                   | 1680                                   | 800                                    |\n| refns. collected   | 10139                                  | 9761                                   | 10191                                  | 8493                                   |\n| unique reflns.     | 3637                                   | 2869                                   | 3572                                   | 3382                                   |\n| R<sub>int</sub>    | 0.0447                                 | 0.0708                                 | 0.0599                                 | 0.0258                                 |\n| R<sub>1</sub>[I\u00a0&gt;\u00a02\u03c3(I)] | 0.0634                          | 0.0470                                 | 0.0612                                 | 0.0651                                 |\n| wR<sub>2</sub>[I\u00a0&gt;\u00a02\u03c3(I)] | 0.2021                          | 0.1020                                 | 0.1437                                 | 0.1702                                 |\n| R<sub>1</sub>(all data) | 0.1092                             | 0.0581                                 | 0.1261                                 | 0.0898                                 |\n| wR<sub>2</sub> (all data) | 0.2620                          | 0.1056                                 | 0.1618                                 | 0.1877                                 |\n| GOF on F<sup>2</sup> | 1.052                                | 1.060                                  | 1.044                                  | 1.065                                  |\n\n[^a]: R<sub>1</sub> = \u2211| |F<sub>o</sub>| \u2013 |F<sub>c</sub>| |/\u2211|F<sub>o</sub>|; wR<sub>2</sub> = \u2211[w(F<sub>o</sub><sup>2</sup> \u2013 F<sub>c</sub><sup>2</sup>)<sup>2</sup>]/\u2211[w(F<sub>o</sub><sup>2</sup>)<sup>2</sup>]<sup>1/2</sup>", "data": [[{"meta": {"name": "", "symbol": "1", "chemical formula": "C\u2082\u2081H\u2082\u2080ClN\u2082NaO\u2085"}, "chemical formula weight": [{"value": "438.83", "unit": "", "condition": ""}], "crystal system": [{"value": "monoclinic", "condition": ""}], "space group": [{"value": "P21/c", "condition": ""}], "lattice parameters": [{"value": {"a": "6.014(2)", "b": "23.279(9)", "c": "15.076(6)", "alpha": "90", "beta": "99.969(7)", "gamma": "90"}, "condition": ""}], "cell volume": [{"value": "2078.9(14)", "unit": "\u00c5^3", "condition": ""}], "density": [{"value": "1.402", "unit": "g/cm^3", "condition": ""}]}, {"meta": {"name": "", "symbol": "2", "chemical formula": "C\u2081\u2089H\u2082\u2081ClN\u2082Na\u2082O\u2088"}, "chemical formula weight": [{"value": "486.81", "unit": "", "condition": ""}], "crystal system": [{"value": "orthorhombic", "condition": ""}], "space group": [{"value": "Pna2(1)", "condition": ""}], "lattice parameters": [{"value": {"a": "34.551(3)", "b": "5.0944(4)", "c": "12.0785(11)", "alpha": "90", "beta": "90", "gamma": "90"}, "condition": ""}], "cell volume": [{"value": "2126.0(3)", "unit": "\u00c5^3", "condition": ""}], "density": [{"value": "1.521", "unit": "g/cm^3", "condition": ""}]}, {"meta": {"name": "", "symbol": "3", "chemical formula": "C\u2082\u2080H\u2081\u2089ClN\u2082O\u2085"}, "chemical formula weight": [{"value": "402.82", "unit": "", "condition": ""}], "crystal system": [{"value": "monoclinic", "condition": ""}], "space group": [{"value": "C2/c", "condition": ""}], "lattice parameters": [{"value": {"a": "23.030(2)", "b": "19.1331(18)", "c": "9.6060(9)", "alpha": "90", "beta": "106.358(2)", "gamma": "90"}, "condition": ""}], "cell volume": [{"value": "4061.4(7)", "unit": "\u00c5^3", "condition": ""}], "density": [{"value": "1.318", "unit": "g/cm^3", "condition": ""}]}, {"meta": {"name": "", "symbol": "4", "chemical formula": "C\u2082\u2080H\u2081\u2087ClN\u2082O\u2084"}, "chemical formula weight": [{"value": "384.81", "unit": "", "condition": ""}], "crystal system": [{"value": "monoclinic", "condition": ""}], "space group": [{"value": "P21c", "condition": ""}], "lattice parameters": [{"value": {"a": "19.7573(15)", "b": "5.0379(3)", "c": "19.5600(12)", "alpha": "90", "beta": "109.887(7)", "gamma": "90"}, "condition": ""}], "cell volume": [{"value": "1830.8(2)", "unit": "\u00c5^3", "condition": ""}], "density": [{"value": "1.396", "unit": "g/cm^3", "condition": ""}]}]], "include_properties": ["chemical_formula", "chemical_formula_weight", "crystal_system", "space_group", "lattice_parameters", "cell_volume", "density"], "intermediate_step": {"table-convert2MD": "[gpt.ft]Table 1. Crystallographic Data for Compounds 1\u20134[^a]\n\n|                    | 1                                      | 2                                      | 3                                      | 4                                      |\n|--------------------|----------------------------------------|----------------------------------------|----------------------------------------|----------------------------------------|\n| formula            | C<sub>21</sub>H<sub>20</sub>ClN<sub>2</sub>NaO<sub>5</sub> | C<sub>19</sub>H<sub>21</sub>ClN<sub>2</sub>Na<sub>2</sub>O<sub>8</sub> | C<sub>20</sub>H<sub>19</sub>ClN<sub>2</sub>O<sub>5</sub> | C<sub>20</sub>H<sub>17</sub>ClN<sub>2</sub>O<sub>4</sub> |\n| formula weight     | 438.83                                 | 486.81                                 | 402.82                                 | 384.81                                 |\n| crystal system     | monoclinic                             | orthorhombic                           | monoclinic                             | monoclinic                             |\n| space group        | P21/c                                  | Pna2(1)                                 | C2/c                                   | P21c                                   |\n| a (\u00c5)               | 6.014(2)                               | 34.551(3)                              | 23.030(2)                              | 19.7573(15)                            |\n| b (\u00c5)               | 23.279(9)                              | 5.0944(4)                              | 19.1331(18)                            | 5.0379(3)                              |\n| c (\u00c5)               | 15.076(6)                              | 12.0785(11)                            | 9.6060(9)                              | 19.5600(12)                            |\n| \u03b1 (deg)             | 90                                     | 90                                     | 90                                     | 90                                     |\n| \u03b2 (deg)             | 99.969(7)                              | 90                                     | 106.358(2)                             | 109.887(7)                             |\n| \u03b3 (deg)             | 90                                     | 90                                     | 90                                     | 90                                     |\n| Z                   | 4                                      | 4                                      | 8                                      | 4                                      |\n| volume (\u00c5<sup>3</sup>) | 2078.9(14)                           | 2126.0(3)                              | 4061.4(7)                              | 1830.8(2)                              |\n| D<sub>calc</sub> (g\u00b7cm<sup>\u20133</sup>) | 1.402                        | 1.521                                  | 1.318                                  | 1.396                                  |\n| F (000)             | 912                                    | 1008                                   | 1680                                   | 800                                    |\n| refns. collected   | 10139                                  | 9761                                   | 10191                                  | 8493                                   |\n| unique reflns.     | 3637                                   | 2869                                   | 3572                                   | 3382                                   |\n| R<sub>int</sub>    | 0.0447                                 | 0.0708                                 | 0.0599                                 | 0.0258                                 |\n| R<sub>1</sub>[I\u00a0&gt;\u00a02\u03c3(I)] | 0.0634                          | 0.0470                                 | 0.0612                                 | 0.0651                                 |\n| wR<sub>2</sub>[I\u00a0&gt;\u00a02\u03c3(I)] | 0.2021                          | 0.1020                                 | 0.1437                                 | 0.1702                                 |\n| R<sub>1</sub>(all data) | 0.1092                             | 0.0581                                 | 0.1261                                 | 0.0898                                 |\n| wR<sub>2</sub> (all data) | 0.2620                          | 0.1056                                 | 0.1618                                 | 0.1877                                 |\n| GOF on F<sup>2</sup> | 1.052                                | 1.060                                  | 1.044                                  | 1.065                                  |\n\n[^a]: R<sub>1</sub> = \u2211| |F<sub>o</sub>| \u2013 |F<sub>c</sub>| |/\u2211|F<sub>o</sub>|; wR<sub>2</sub> = \u2211[w(F<sub>o</sub><sup>2</sup> \u2013 F<sub>c</sub><sup>2</sup>)<sup>2</sup>]/\u2211[w(F<sub>o</sub><sup>2</sup>)<sup>2</sup>]<sup>1/2</sup>\n<END>", "table-categorize": "Crystal", "table-crystal-categorize": "```JSON\n[\n    {\n        \"meta\": {\n            \"name\": \"\",\n            \"symbol\": \"1\",\n            \"chemical formula\": \"C\u2082\u2081H\u2082\u2080ClN\u2082NaO\u2085\",\n        },\n        \"chemical formula weight\": [\n            {\n                \"value\": \"438.83\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            },\n        ],\n        \"crystal system\": [\n            {\n                \"value\": \"monoclinic\",\n                \"condition\": \"\",\n            },\n        ],\n        \"space group\": [\n            {\n                \"value\": \"P21/c\",\n                \"condition\": \"\",\n            },\n        ],\n        \"lattice parameters\": [\n            {\n                \"value\": {\n                    \"a\": \"6.014(2)\",\n                    \"b\": \"23.279(9)\",\n                    \"c\": \"15.076(6)\",\n                    \"alpha\": \"90\",\n                    \"beta\": \"99.969(7)\",\n                    \"gamma\": \"90\",\n                },\n                \"condition\": \"\",\n            },\n        ],\n        \"cell volume\": [\n            {\n                \"value\": \"2078.9(14)\",\n                \"unit\": \"\u00c5^3\",\n                \"condition\": \"\",\n            },\n        ],\n        \"density\": [\n            {\n                \"value\": \"1.402\",\n                \"unit\": \"g/cm^3\",\n                \"condition\": \"\",\n            },\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"\",\n            \"symbol\": \"2\",\n            \"chemical formula\": \"C\u2081\u2089H\u2082\u2081ClN\u2082Na\u2082O\u2088\",\n        },\n        \"chemical formula weight\": [\n            {\n                \"value\": \"486.81\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            },\n        ],\n        \"crystal system\": [\n            {\n                \"value\": \"orthorhombic\",\n                \"condition\": \"\",\n            },\n        ],\n        \"space group\": [\n            {\n                \"value\": \"Pna2(1)\",\n                \"condition\": \"\",\n            },\n        ],\n        \"lattice parameters\": [\n            {\n                \"value\": {\n                    \"a\": \"34.551(3)\",\n                    \"b\": \"5.0944(4)\",\n                    \"c\": \"12.0785(11)\",\n                    \"alpha\": \"90\",\n                    \"beta\": \"90\",\n                    \"gamma\": \"90\",\n                },\n                \"condition\": \"\",\n            },\n        ],\n        \"cell volume\": [\n            {\n                \"value\": \"2126.0(3)\",\n                \"unit\": \"\u00c5^3\",\n                \"condition\": \"\",\n            },\n        ],\n        \"density\": [\n            {\n                \"value\": \"1.521\",\n                \"unit\": \"g/cm^3\",\n                \"condition\": \"\",\n            },\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"\",\n            \"symbol\": \"3\",\n            \"chemical formula\": \"C\u2082\u2080H\u2081\u2089ClN\u2082O\u2085\",\n        },\n        \"chemical formula weight\": [\n            {\n                \"value\": \"402.82\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            },\n        ],\n        \"crystal system\": [\n            {\n                \"value\": \"monoclinic\",\n                \"condition\": \"\",\n            },\n        ],\n        \"space group\": [\n            {\n                \"value\": \"C2/c\",\n                \"condition\": \"\",\n            },\n        ],\n        \"lattice parameters\": [\n            {\n                \"value\": {\n                    \"a\": \"23.030(2)\",\n                    \"b\": \"19.1331(18)\",\n                    \"c\": \"9.6060(9)\",\n                    \"alpha\": \"90\",\n                    \"beta\": \"106.358(2)\",\n                    \"gamma\": \"90\",\n                },\n                \"condition\": \"\",\n            },\n        ],\n        \"cell volume\": [\n            {\n                \"value\": \"4061.4(7)\",\n                \"unit\": \"\u00c5^3\",\n                \"condition\": \"\",\n            },\n        ],\n        \"density\": [\n            {\n                \"value\": \"1.318\",\n                \"unit\": \"g/cm^3\",\n                \"condition\": \"\",\n            },\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"\",\n            \"symbol\": \"4\",\n            \"chemical formula\": \"C\u2082\u2080H\u2081\u2087ClN\u2082O\u2084\",\n        },\n        \"chemical formula weight\": [\n            {\n                \"value\": \"384.81\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            },\n        ],\n        \"crystal system\": [\n            {\n                \"value\": \"monoclinic\",\n                \"condition\": \"\",\n            },\n        ],\n        \"space group\": [\n            {\n                \"value\": \"P21c\",\n                \"condition\": \"\",\n            },\n        ],\n        \"lattice parameters\": [\n            {\n                \"value\": {\n                    \"a\": \"19.7573(15)\",\n                    \"b\": \"5.0379(3)\",\n                    \"c\": \"19.5600(12)\",\n                    \"alpha\": \"90\",\n                    \"beta\": \"109.887(7)\",\n                    \"gamma\": \"90\",\n                },\n                \"condition\": \"\",\n            },\n        ],\n        \"cell volume\": [\n            {\n                \"value\": \"1830.8(2)\",\n                \"unit\": \"\u00c5^3\",\n                \"condition\": \"\",\n            },\n        ],\n        \"density\": [\n            {\n                \"value\": \"1.396\",\n                \"unit\": \"g/cm^3\",\n                \"condition\": \"\",\n            },\n        ],\n    },\n]\n```"}}, {"idx": 14, "type": "table", "classification": ["Bond & Angle"], "content": "<table-wrap id=\"tbl2\" position=\"float\">\n<label>2</label>\n<caption>\n<title>Hydrogen Bonding\nInteractions in Compounds <bold>1</bold>\u2013<bold>4</bold>\n</title>\n</caption>\n<oasis:table colsep=\"0\" rowsep=\"0\">\n<oasis:tgroup cols=\"6\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col3\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col4\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col5\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col6\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\">D\u2013H\u00b7\u00b7\u00b7A</oasis:entry>\n<oasis:entry align=\"center\">D\u2013H/\u00c5</oasis:entry>\n<oasis:entry align=\"center\">H\u00b7\u00b7\u00b7A/\u00c5</oasis:entry>\n<oasis:entry align=\"center\">D\u00b7\u00b7\u00b7A/\u00c5</oasis:entry>\n<oasis:entry align=\"center\">D\u2013H\u00b7\u00b7\u00b7A/\u00b0</oasis:entry>\n<oasis:entry align=\"center\">symmetry code</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>compound <bold>1</bold>\n</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>N1\u2013H1\u00b7\u00b7\u00b7O1</oasis:entry>\n<oasis:entry>0.860</oasis:entry>\n<oasis:entry>2.004</oasis:entry>\n<oasis:entry>2.858</oasis:entry>\n<oasis:entry>172.05</oasis:entry>\n<oasis:entry>\u2013x+2, \u2013y+1, -z+1</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>N2\u2013H2A\u00b7\u00b7\u00b7O1</oasis:entry>\n<oasis:entry>0.860</oasis:entry>\n<oasis:entry>2.338</oasis:entry>\n<oasis:entry>3.102</oasis:entry>\n<oasis:entry>148.23</oasis:entry>\n<oasis:entry>x\u20131, y, z</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>O5\u2013H5A\u00b7\u00b7\u00b7O4</oasis:entry>\n<oasis:entry>0.849</oasis:entry>\n<oasis:entry>1.818</oasis:entry>\n<oasis:entry>2.685</oasis:entry>\n<oasis:entry>169.92</oasis:entry>\n<oasis:entry>x\u20131, y, z</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>compound <bold>2</bold>\n</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>N2\u2013H2A\u00b7\u00b7\u00b7O2</oasis:entry>\n<oasis:entry>0.860</oasis:entry>\n<oasis:entry>2.333</oasis:entry>\n<oasis:entry>3.175</oasis:entry>\n<oasis:entry>166.11</oasis:entry>\n<oasis:entry>x, y\u20131, z</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>O5\u2013H5A\u00b7\u00b7\u00b7O1</oasis:entry>\n<oasis:entry>0.970</oasis:entry>\n<oasis:entry>1.886</oasis:entry>\n<oasis:entry>2.720</oasis:entry>\n<oasis:entry>142.54</oasis:entry>\n<oasis:entry>\u2013x+1, \u2212y, z\u20131/2</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>O5\u2013H5B\u00a0\u00b7\u00b7\u00b7N1</oasis:entry>\n<oasis:entry>0.970</oasis:entry>\n<oasis:entry>2.492</oasis:entry>\n<oasis:entry>3.203</oasis:entry>\n<oasis:entry>130.03</oasis:entry>\n<oasis:entry>\u2013x+1, \u2013y+1, z\u20131/2</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>O6\u2013H6A\u00b7\u00b7\u00b7N1</oasis:entry>\n<oasis:entry>0.850</oasis:entry>\n<oasis:entry>2.078</oasis:entry>\n<oasis:entry>2.920</oasis:entry>\n<oasis:entry>170.47</oasis:entry>\n<oasis:entry>x, y\u20131, z</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>O6\u2013H6B\u00b7\u00b7\u00b7O4</oasis:entry>\n<oasis:entry>0.850</oasis:entry>\n<oasis:entry>2.036</oasis:entry>\n<oasis:entry>2.839</oasis:entry>\n<oasis:entry>157.29</oasis:entry>\n<oasis:entry>\u2013x+1, \u2212y, z\u20131/2</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>O7\u2013H7A\u00b7\u00b7\u00b7O8</oasis:entry>\n<oasis:entry>0.970</oasis:entry>\n<oasis:entry>1.964</oasis:entry>\n<oasis:entry>2.726</oasis:entry>\n<oasis:entry>133.78</oasis:entry>\n<oasis:entry>intramolecular</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>O7\u2013H7B\u00b7\u00b7\u00b7N1</oasis:entry>\n<oasis:entry>0.970</oasis:entry>\n<oasis:entry>2.262</oasis:entry>\n<oasis:entry>2.871</oasis:entry>\n<oasis:entry>119.81</oasis:entry>\n<oasis:entry>\u2013x+1,\n\u2212y, z\u20131/2</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>O8\u2013H8A\u00b7\u00b7\u00b7O4</oasis:entry>\n<oasis:entry>0.852</oasis:entry>\n<oasis:entry>1.922</oasis:entry>\n<oasis:entry>2.772</oasis:entry>\n<oasis:entry>174.68</oasis:entry>\n<oasis:entry>\u2013x+1, \u2212y, z\u20131/2</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>O8\u2013H8B\u00b7\u00b7\u00b7O2</oasis:entry>\n<oasis:entry>0.851</oasis:entry>\n<oasis:entry>1.961</oasis:entry>\n<oasis:entry>2.785</oasis:entry>\n<oasis:entry>162.71</oasis:entry>\n<oasis:entry>\u2013x+1, \u2013y+1, z\u20131/2</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>compound <bold>3</bold>\n</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>N1\u2013H1\u00b7\u00b7\u00b7O3</oasis:entry>\n<oasis:entry>0.860</oasis:entry>\n<oasis:entry>2.026</oasis:entry>\n<oasis:entry>2.883</oasis:entry>\n<oasis:entry>174.03</oasis:entry>\n<oasis:entry>\u2013x+3/2,y+1/2,\u2013z+1/2</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>N2\u2013H2A\u00b7\u00b7\u00b7O2</oasis:entry>\n<oasis:entry>0.860</oasis:entry>\n<oasis:entry>2.122</oasis:entry>\n<oasis:entry>2.869</oasis:entry>\n<oasis:entry>144.90</oasis:entry>\n<oasis:entry>x, \u2013y+1, z\u20131/2</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>O4\u2013H4B\u00b7\u00b7\u00b7O5</oasis:entry>\n<oasis:entry>0.850</oasis:entry>\n<oasis:entry>1.782</oasis:entry>\n<oasis:entry>2.609</oasis:entry>\n<oasis:entry>163.88</oasis:entry>\n<oasis:entry>intramolecular</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>O5\u2013H5A\u00b7\u00b7\u00b7O1</oasis:entry>\n<oasis:entry>0.820</oasis:entry>\n<oasis:entry>1.979</oasis:entry>\n<oasis:entry>2.701</oasis:entry>\n<oasis:entry>146.53</oasis:entry>\n<oasis:entry>\u2013x+3/2,y\u20131/2, \u2013z+1/2</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>O5\u2013H5B\u00b7\u00b7\u00b7O1</oasis:entry>\n<oasis:entry>0.850</oasis:entry>\n<oasis:entry>2.018</oasis:entry>\n<oasis:entry>2.701</oasis:entry>\n<oasis:entry>136.78</oasis:entry>\n<oasis:entry>\u2013x+3/2,y\u20131/2, \u2013z+1/2</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>compound <bold>4</bold>\n</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>N1\u2013H1\u00b7\u00b7\u00b7O1</oasis:entry>\n<oasis:entry>0.860</oasis:entry>\n<oasis:entry>1.972</oasis:entry>\n<oasis:entry>2.826</oasis:entry>\n<oasis:entry>172.10</oasis:entry>\n<oasis:entry>x, y\u20131, z</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>N2\u2013H2A\u00b7\u00b7\u00b7O2</oasis:entry>\n<oasis:entry>0.860</oasis:entry>\n<oasis:entry>2.007</oasis:entry>\n<oasis:entry>2.923</oasis:entry>\n<oasis:entry>167.62</oasis:entry>\n<oasis:entry>\u2013x,y+1/2,\u2013z\u20131/2</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n</table-wrap>", "clean_text": "Table 2. Hydrogen Bonding Interactions in Compounds 1\u20134\n\n| D\u2013H\u00b7\u00b7\u00b7A | D\u2013H/\u00c5 | H\u00b7\u00b7\u00b7A/\u00c5 | D\u00b7\u00b7\u00b7A/\u00c5 | D\u2013H\u00b7\u00b7\u00b7A/\u00b0 | symmetry code |\n|---------|-------|---------|---------|-----------|---------------|\n| compound 1 |       |         |         |           |               |\n| N1\u2013H1\u00b7\u00b7\u00b7O1 | 0.860 | 2.004   | 2.858   | 172.05    | \u2013x+2, \u2013y+1, -z+1 |\n| N2\u2013H2A\u00b7\u00b7\u00b7O1 | 0.860 | 2.338 | 3.102   | 148.23    | x\u20131, y, z     |\n| O5\u2013H5A\u00b7\u00b7\u00b7O4 | 0.849 | 1.818 | 2.685   | 169.92    | x\u20131, y, z     |\n| compound 2 |       |         |         |           |               |\n| N2\u2013H2A\u00b7\u00b7\u00b7O2 | 0.860 | 2.333   | 3.175   | 166.11    | x, y\u20131, z     |\n| O5\u2013H5A\u00b7\u00b7\u00b7O1 | 0.970 | 1.886 | 2.720   | 142.54    | \u2013x+1, \u2212y, z\u20131/2 |\n| O5\u2013H5B\u00a0\u00b7\u00b7\u00b7N1 | 0.970 | 2.492 | 3.203   | 130.03    | \u2013x+1, \u2013y+1, z\u20131/2 |\n| O6\u2013H6A\u00b7\u00b7\u00b7N1 | 0.850 | 2.078 | 2.920   | 170.47    | x, y\u20131, z     |\n| O6\u2013H6B\u00b7\u00b7\u00b7O4 | 0.850 | 2.036 | 2.839   | 157.29    | \u2013x+1, \u2212y, z\u20131/2 |\n| O7\u2013H7A\u00b7\u00b7\u00b7O8 | 0.970 | 1.964 | 2.726   | 133.78    | intramolecular |\n| O7\u2013H7B\u00b7\u00b7\u00b7N1 | 0.970 | 2.262 | 2.871   | 119.81    | \u2013x+1, \u2212y, z\u20131/2 |\n| O8\u2013H8A\u00b7\u00b7\u00b7O4 | 0.852 | 1.922 | 2.772   | 174.68    | \u2013x+1, \u2212y, z\u20131/2 |\n| O8\u2013H8B\u00b7\u00b7\u00b7O2 | 0.851 | 1.961 | 2.785   | 162.71    | \u2013x+1, \u2013y+1, z\u20131/2 |\n| compound 3 |       |         |         |           |               |\n| N1\u2013H1\u00b7\u00b7\u00b7O3 | 0.860 | 2.026   | 2.883   | 174.03    | \u2013x+3/2,y+1/2,\u2013z+1/2 |\n| N2\u2013H2A\u00b7\u00b7\u00b7O2 | 0.860 | 2.122   | 2.869   | 144.90    | x, \u2013y+1, z\u20131/2 |\n| O4\u2013H4B\u00b7\u00b7\u00b7O5 | 0.850 | 1.782 | 2.609   | 163.88    | intramolecular |\n| O5\u2013H5A\u00b7\u00b7\u00b7O1 | 0.820 | 1.979 | 2.701   | 146.53    | \u2013x+3/2,y\u20131/2, \u2013z+1/2 |\n| O5\u2013H5B\u00b7\u00b7\u00b7O1 | 0.850 | 2.018 | 2.701   | 136.78    | \u2013x+3/2,y\u20131/2, \u2013z+1/2 |\n| compound 4 |       |         |         |           |               |\n| N1\u2013H1\u00b7\u00b7\u00b7O1 | 0.860 | 1.972   | 2.826   | 172.10    | x, y\u20131, z     |\n| N2\u2013H2A\u00b7\u00b7\u00b7O2 | 0.860 | 2.007   | 2.923   | 167.62    | \u2013x,y+1/2,\u2013z\u20131/2 |", "data": [["Bond & Angle type of table is not target"]], "include_properties": null, "intermediate_step": {"table-convert2MD": "[gpt.ft]Table 2. Hydrogen Bonding Interactions in Compounds 1\u20134\n\n| D\u2013H\u00b7\u00b7\u00b7A | D\u2013H/\u00c5 | H\u00b7\u00b7\u00b7A/\u00c5 | D\u00b7\u00b7\u00b7A/\u00c5 | D\u2013H\u00b7\u00b7\u00b7A/\u00b0 | symmetry code |\n|---------|-------|---------|---------|-----------|---------------|\n| compound 1 |       |         |         |           |               |\n| N1\u2013H1\u00b7\u00b7\u00b7O1 | 0.860 | 2.004   | 2.858   | 172.05    | \u2013x+2, \u2013y+1, -z+1 |\n| N2\u2013H2A\u00b7\u00b7\u00b7O1 | 0.860 | 2.338 | 3.102   | 148.23    | x\u20131, y, z     |\n| O5\u2013H5A\u00b7\u00b7\u00b7O4 | 0.849 | 1.818 | 2.685   | 169.92    | x\u20131, y, z     |\n| compound 2 |       |         |         |           |               |\n| N2\u2013H2A\u00b7\u00b7\u00b7O2 | 0.860 | 2.333   | 3.175   | 166.11    | x, y\u20131, z     |\n| O5\u2013H5A\u00b7\u00b7\u00b7O1 | 0.970 | 1.886 | 2.720   | 142.54    | \u2013x+1, \u2212y, z\u20131/2 |\n| O5\u2013H5B\u00a0\u00b7\u00b7\u00b7N1 | 0.970 | 2.492 | 3.203   | 130.03    | \u2013x+1, \u2013y+1, z\u20131/2 |\n| O6\u2013H6A\u00b7\u00b7\u00b7N1 | 0.850 | 2.078 | 2.920   | 170.47    | x, y\u20131, z     |\n| O6\u2013H6B\u00b7\u00b7\u00b7O4 | 0.850 | 2.036 | 2.839   | 157.29    | \u2013x+1, \u2212y, z\u20131/2 |\n| O7\u2013H7A\u00b7\u00b7\u00b7O8 | 0.970 | 1.964 | 2.726   | 133.78    | intramolecular |\n| O7\u2013H7B\u00b7\u00b7\u00b7N1 | 0.970 | 2.262 | 2.871   | 119.81    | \u2013x+1, \u2212y, z\u20131/2 |\n| O8\u2013H8A\u00b7\u00b7\u00b7O4 | 0.852 | 1.922 | 2.772   | 174.68    | \u2013x+1, \u2212y, z\u20131/2 |\n| O8\u2013H8B\u00b7\u00b7\u00b7O2 | 0.851 | 1.961 | 2.785   | 162.71    | \u2013x+1, \u2013y+1, z\u20131/2 |\n| compound 3 |       |         |         |           |               |\n| N1\u2013H1\u00b7\u00b7\u00b7O3 | 0.860 | 2.026   | 2.883   | 174.03    | \u2013x+3/2,y+1/2,\u2013z+1/2 |\n| N2\u2013H2A\u00b7\u00b7\u00b7O2 | 0.860 | 2.122   | 2.869   | 144.90    | x, \u2013y+1, z\u20131/2 |\n| O4\u2013H4B\u00b7\u00b7\u00b7O5 | 0.850 | 1.782 | 2.609   | 163.88    | intramolecular |\n| O5\u2013H5A\u00b7\u00b7\u00b7O1 | 0.820 | 1.979 | 2.701   | 146.53    | \u2013x+3/2,y\u20131/2, \u2013z+1/2 |\n| O5\u2013H5B\u00b7\u00b7\u00b7O1 | 0.850 | 2.018 | 2.701   | 136.78    | \u2013x+3/2,y\u20131/2, \u2013z+1/2 |\n| compound 4 |       |         |         |           |               |\n| N1\u2013H1\u00b7\u00b7\u00b7O1 | 0.860 | 1.972   | 2.826   | 172.10    | x, y\u20131, z     |\n| N2\u2013H2A\u00b7\u00b7\u00b7O2 | 0.860 | 2.007   | 2.923   | 167.62    | \u2013x,y+1/2,\u2013z\u20131/2 |\n<END>", "table-categorize": "Bond & Angle"}}, {"idx": 43, "type": "table", "classification": ["Property"], "content": "<table-wrap id=\"tbl3\" position=\"float\">\n<label>3</label>\n<caption>\n<title>PK Data\nof the Original API and Compounds <bold>1-4</bold>\n</title>\n</caption>\n<oasis:table colsep=\"0\" rowsep=\"0\">\n<oasis:tgroup cols=\"5\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col3\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col4\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col5\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\">drug</oasis:entry>\n<oasis:entry align=\"center\">\n<italic>C</italic>\n<sub>max</sub>(ng/mL)</oasis:entry>\n<oasis:entry align=\"center\">\n<italic>t</italic>\n<sub>max</sub>(h)</oasis:entry>\n<oasis:entry align=\"center\">AUC (ng\u00b7h/mL)</oasis:entry>\n<oasis:entry align=\"center\">\n<italic>F</italic> (%)</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>original API</oasis:entry>\n<oasis:entry>202.5</oasis:entry>\n<oasis:entry>3.00</oasis:entry>\n<oasis:entry>1694.0</oasis:entry>\n<oasis:entry>100.0</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>compound <bold>1</bold>\n</oasis:entry>\n<oasis:entry>239.3</oasis:entry>\n<oasis:entry>3.00</oasis:entry>\n<oasis:entry>2052.4</oasis:entry>\n<oasis:entry>121.2</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>compound <bold>2</bold>\n</oasis:entry>\n<oasis:entry>53.82</oasis:entry>\n<oasis:entry>0.50</oasis:entry>\n<oasis:entry>948.20</oasis:entry>\n<oasis:entry>56.00</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>compound <bold>3</bold>\n</oasis:entry>\n<oasis:entry>227.2</oasis:entry>\n<oasis:entry>6.00</oasis:entry>\n<oasis:entry>2348.5</oasis:entry>\n<oasis:entry>138.6</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>compound <bold>4</bold>\n</oasis:entry>\n<oasis:entry>355.0</oasis:entry>\n<oasis:entry>4.00</oasis:entry>\n<oasis:entry>3229.8</oasis:entry>\n<oasis:entry>190.7</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n</table-wrap>", "clean_text": "Table 3. PK Data of the Original API and Compounds 1-4\n\n| drug          | C<sub>max</sub>(ng/mL) | t<sub>max</sub>(h) | AUC (ng\u00b7h/mL) | F (%) |\n|---------------|-----------------------|-------------------|--------------|------|\n| original API  | 202.5                 | 3.00              | 1694.0       | 100.0|\n| compound 1    | 239.3                 | 3.00              | 2052.4       | 121.2|\n| compound 2    | 53.82                 | 0.50              | 948.20       | 56.00|\n| compound 3    | 227.2                 | 6.00              | 2348.5       | 138.6|\n| compound 4    | 355.0                 | 4.00              | 3229.8       | 190.7|", "data": [[{"meta": {"name": "original API", "symbol": "", "chemical formula": ""}, "etc": [{"property name": "Cmax", "value": "202.5", "unit": "ng/mL", "condition": ""}, {"property name": "tmax", "value": "3.00", "unit": "h", "condition": ""}, {"property name": "AUC", "value": "1694.0", "unit": "ng\u00b7h/mL", "condition": ""}, {"property name": "F", "value": "100.0", "unit": "%", "condition": ""}]}, {"meta": {"name": "compound 1", "symbol": "", "chemical formula": ""}, "etc": [{"property name": "Cmax", "value": "239.3", "unit": "ng/mL", "condition": ""}, {"property name": "tmax", "value": "3.00", "unit": "h", "condition": ""}, {"property name": "AUC", "value": "2052.4", "unit": "ng\u00b7h/mL", "condition": ""}, {"property name": "F", "value": "121.2", "unit": "%", "condition": ""}]}, {"meta": {"name": "compound 2", "symbol": "", "chemical formula": ""}, "etc": [{"property name": "Cmax", "value": "53.82", "unit": "ng/mL", "condition": ""}, {"property name": "tmax", "value": "0.50", "unit": "h", "condition": ""}, {"property name": "AUC", "value": "948.20", "unit": "ng\u00b7h/mL", "condition": ""}, {"property name": "F", "value": "56.00", "unit": "%", "condition": ""}]}, {"meta": {"name": "compound 3", "symbol": "", "chemical formula": ""}, "etc": [{"property name": "Cmax", "value": "227.2", "unit": "ng/mL", "condition": ""}, {"property name": "tmax", "value": "6.00", "unit": "h", "condition": ""}, {"property name": "AUC", "value": "2348.5", "unit": "ng\u00b7h/mL", "condition": ""}, {"property name": "F", "value": "138.6", "unit": "%", "condition": ""}]}, {"meta": {"name": "compound 4", "symbol": "", "chemical formula": ""}, "etc": [{"property name": "Cmax", "value": "355.0", "unit": "ng/mL", "condition": ""}, {"property name": "tmax", "value": "4.00", "unit": "h", "condition": ""}, {"property name": "AUC", "value": "3229.8", "unit": "ng\u00b7h/mL", "condition": ""}, {"property name": "F", "value": "190.7", "unit": "%", "condition": ""}]}]], "include_properties": ["etc"], "intermediate_step": {"table-convert2MD": "[gpt.ft]Table 3. PK Data of the Original API and Compounds 1-4\n\n| drug          | C<sub>max</sub>(ng/mL) | t<sub>max</sub>(h) | AUC (ng\u00b7h/mL) | F (%) |\n|---------------|-----------------------|-------------------|--------------|------|\n| original API  | 202.5                 | 3.00              | 1694.0       | 100.0|\n| compound 1    | 239.3                 | 3.00              | 2052.4       | 121.2|\n| compound 2    | 53.82                 | 0.50              | 948.20       | 56.00|\n| compound 3    | 227.2                 | 6.00              | 2348.5       | 138.6|\n| compound 4    | 355.0                 | 4.00              | 3229.8       | 190.7|\n<END>", "table-categorize": "Property", "table-property-type": "['etc']", "table-property-extract": "```JSON\n[\n    {\n        \"meta\": {\n            \"name\": \"original API\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"\",\n        },\n        \"etc\": [\n            {\n                \"property name\": \"Cmax\",\n                \"value\": \"202.5\",\n                \"unit\": \"ng/mL\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"tmax\",\n                \"value\": \"3.00\",\n                \"unit\": \"h\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"AUC\",\n                \"value\": \"1694.0\",\n                \"unit\": \"ng\u00b7h/mL\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"F\",\n                \"value\": \"100.0\",\n                \"unit\": \"%\",\n                \"condition\": \"\",\n            }\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"compound 1\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"\",\n        },\n        \"etc\": [\n            {\n                \"property name\": \"Cmax\",\n                \"value\": \"239.3\",\n                \"unit\": \"ng/mL\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"tmax\",\n                \"value\": \"3.00\",\n                \"unit\": \"h\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"AUC\",\n                \"value\": \"2052.4\",\n                \"unit\": \"ng\u00b7h/mL\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"F\",\n                \"value\": \"121.2\",\n                \"unit\": \"%\",\n                \"condition\": \"\",\n            }\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"compound 2\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"\",\n        },\n        \"etc\": [\n            {\n                \"property name\": \"Cmax\",\n                \"value\": \"53.82\",\n                \"unit\": \"ng/mL\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"tmax\",\n                \"value\": \"0.50\",\n                \"unit\": \"h\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"AUC\",\n                \"value\": \"948.20\",\n                \"unit\": \"ng\u00b7h/mL\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"F\",\n                \"value\": \"56.00\",\n                \"unit\": \"%\",\n                \"condition\": \"\",\n            }\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"compound 3\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"\",\n        },\n        \"etc\": [\n            {\n                \"property name\": \"Cmax\",\n                \"value\": \"227.2\",\n                \"unit\": \"ng/mL\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"tmax\",\n                \"value\": \"6.00\",\n                \"unit\": \"h\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"AUC\",\n                \"value\": \"2348.5\",\n                \"unit\": \"ng\u00b7h/mL\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"F\",\n                \"value\": \"138.6\",\n                \"unit\": \"%\",\n                \"condition\": \"\",\n            }\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"compound 4\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"\",\n        },\n        \"etc\": [\n            {\n                \"property name\": \"Cmax\",\n                \"value\": \"355.0\",\n                \"unit\": \"ng/mL\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"tmax\",\n                \"value\": \"4.00\",\n                \"unit\": \"h\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"AUC\",\n                \"value\": \"3229.8\",\n                \"unit\": \"ng\u00b7h/mL\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"F\",\n                \"value\": \"190.7\",\n                \"unit\": \"%\",\n                \"condition\": \"\",\n            }\n        ],\n    }\n]\n```"}}, {"idx": 4, "type": "figure", "classification": null, "content": "<fig fig-type=\"scheme\" id=\"sch1\" position=\"float\">\n<label>1</label>\n<caption>\n<title>Molecular Structure of Rebamipide</title>\n</caption>\n<graphic id=\"gr1\" position=\"float\" xlink:href=\"cg-2015-01839n_0012.tif\"></graphic>\n</fig>", "clean_text": " 1  Molecular Structure of Rebamipide   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 19, "type": "figure", "classification": null, "content": "<fig id=\"fig1\" position=\"float\">\n<label>1</label>\n<caption>\n<p>An asymmetric unit of\nsalt <bold>1</bold>.</p>\n</caption>\n<graphic id=\"gr4\" position=\"float\" xlink:href=\"cg-2015-01839n_0002.tif\"></graphic>\n</fig>", "clean_text": " 1  An asymmetric unit of salt 1.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 20, "type": "figure", "classification": null, "content": "<fig id=\"fig2\" position=\"float\">\n<label>2</label>\n<caption>\n<p>(a) 1D chain in salt <bold>1</bold>. (b) 2D supermolecular network\nformed by hydrogen bonding interactions of N1\u2013H\u00b7\u00b7\u00b7O3.\nH atoms are omitted for the sake of clarity and green dashed lines\nrepresent the hydrogen bonding interactions.</p>\n</caption>\n<graphic id=\"gr5\" position=\"float\" xlink:href=\"cg-2015-01839n_0003.tif\"></graphic>\n</fig>", "clean_text": " 2  (a) 1D chain in salt 1. (b) 2D supermolecular network formed by hydrogen bonding interactions of N1-H\u22c5\u22c5\u22c5O3. H atoms are omitted for the sake of clarity and green dashed lines represent the hydrogen bonding interactions.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 22, "type": "figure", "classification": null, "content": "<fig id=\"fig3\" position=\"float\">\n<label>3</label>\n<caption>\n<p>An asymmetric unit of salt <bold>2</bold>.</p>\n</caption>\n<graphic id=\"gr6\" position=\"float\" xlink:href=\"cg-2015-01839n_0004.tif\"></graphic>\n</fig>", "clean_text": " 3  An asymmetric unit of salt 2.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 23, "type": "figure", "classification": null, "content": "<fig fig-type=\"scheme\" id=\"sch2\" position=\"float\">\n<label>2</label>\n<caption>\n<title>Equilibrium between Two Tautomers</title>\n</caption>\n<graphic id=\"gr2\" position=\"float\" xlink:href=\"cg-2015-01839n_0013.tif\"></graphic>\n</fig>", "clean_text": " 2  Equilibrium between Two Tautomers   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 25, "type": "figure", "classification": null, "content": "<fig id=\"fig4\" position=\"float\">\n<label>4</label>\n<caption>\n<p>(a) 1D chain in salt <bold>2</bold>. (b) 2D sheet formed by Na\u00b7\u00b7\u00b7O\nweak interactions on <italic>bc</italic> plane. (c) The view of the\n2D sheet along <italic>b</italic>-axis. H atoms are omitted for the\nsake of clarity and green-blue dashed lines represent the weak Na\u00b7\u00b7\u00b7O\ninteractions.</p>\n</caption>\n<graphic id=\"gr7\" position=\"float\" xlink:href=\"cg-2015-01839n_0005.tif\"></graphic>\n</fig>", "clean_text": " 4  (a) 1D chain in salt 2. (b) 2D sheet formed by Na\u22c5\u22c5\u22c5O weak interactions on bc plane. (c) The view of the 2D sheet along b-axis. H atoms are omitted for the sake of clarity and green-blue dashed lines represent the weak Na\u22c5\u22c5\u22c5O interactions.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 27, "type": "figure", "classification": null, "content": "<fig id=\"fig5\" position=\"float\">\n<label>5</label>\n<caption>\n<p>An asymmetric unit of solvate <bold>3</bold>.</p>\n</caption>\n<graphic id=\"gr8\" position=\"float\" xlink:href=\"cg-2015-01839n_0006.tif\"></graphic>\n</fig>", "clean_text": " 5  An asymmetric unit of solvate 3.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 28, "type": "figure", "classification": null, "content": "<fig id=\"fig6\" position=\"float\">\n<label>6</label>\n<caption>\n<p>(a) 1D chain formed by hydrogen bonding in <bold>3</bold>. (b)\n2D supermolecular network on <italic>bc</italic> plane. H atoms are\nomitted for the sake of clarity and green dashed lines represent the\nhydrogen bonding interactions.</p>\n</caption>\n<graphic id=\"gr9\" position=\"float\" xlink:href=\"cg-2015-01839n_0007.tif\"></graphic>\n</fig>", "clean_text": " 6  (a) 1D chain formed by hydrogen bonding in 3. (b) 2D supermolecular network on bc plane. H atoms are omitted for the sake of clarity and green dashed lines represent the hydrogen bonding interactions.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 30, "type": "figure", "classification": null, "content": "<fig id=\"fig7\" position=\"float\">\n<label>7</label>\n<caption>\n<p>(a) An asymmetric unit of rebamipide methyl ester <bold>4</bold>. (b) 1D double chain assembled by hydrogen bonding interactions.</p>\n</caption>\n<graphic id=\"gr10\" position=\"float\" xlink:href=\"cg-2015-01839n_0008.tif\"></graphic>\n</fig>", "clean_text": " 7  (a) An asymmetric unit of rebamipide methyl ester 4. (b) 1D double chain assembled by hydrogen bonding interactions.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 34, "type": "figure", "classification": null, "content": "<fig fig-type=\"scheme\" id=\"sch3\" position=\"float\">\n<label>3</label>\n<caption>\n<title>Equilibrium between Rebamipide and its Methyl Ester</title>\n</caption>\n<graphic id=\"gr3\" position=\"float\" xlink:href=\"cg-2015-01839n_0014.tif\"></graphic>\n</fig>", "clean_text": " 3  Equilibrium between Rebamipide and its Methyl Ester   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 37, "type": "figure", "classification": null, "content": "<fig id=\"fig8\" position=\"float\">\n<label>8</label>\n<caption>\n<p>TG (black) and DSC (red) thermograms of compounds <bold>1</bold>\u2013<bold>4</bold>.</p>\n</caption>\n<graphic id=\"gr11\" position=\"float\" xlink:href=\"cg-2015-01839n_0009.tif\"></graphic>\n</fig>", "clean_text": " 8  TG (black) and DSC (red) thermograms of compounds 1-4.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 40, "type": "figure", "classification": null, "content": "<fig id=\"fig9\" position=\"float\">\n<label>9</label>\n<caption>\n<p>Dissolution\nprofiles of API and compounds <bold>1</bold>\u2013<bold>4</bold> in HCl solution (pH = 1.2) within (a) 35 min and (b) 36\nh.</p>\n</caption>\n<graphic id=\"gr12\" position=\"float\" xlink:href=\"cg-2015-01839n_0010.tif\"></graphic>\n</fig>", "clean_text": " 9  Dissolution profiles of API and compounds 1-4 in HCl solution (pH = 1.2) within (a) 35 min and (b) 36 h.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 42, "type": "figure", "classification": null, "content": "<fig id=\"fig10\" position=\"float\">\n<label>10</label>\n<caption>\n<p>Mean plasma\nconcentration vs time profiles of original API and\ncompounds <bold>1</bold>\u2013<bold>4</bold> in rats after oral\nadministration.</p>\n</caption>\n<graphic id=\"gr13\" position=\"float\" xlink:href=\"cg-2015-01839n_0011.tif\"></graphic>\n</fig>", "clean_text": " 10  Mean plasma concentration vs time profiles of original API and compounds 1-4 in rats after oral administration.   ", "data": null, "include_properties": null, "intermediate_step": {}}], "metadata": {"doi": "10.1021/acs.cgd.5b01839", "title": "\nSodium Salts and Solvate of Rebamipide: Synthesis,\nStructure, and Pharmacokinetic Study\n", "journal": "American Chemical\nSociety", "date": "2016.05", "author_list": ["Chi\nYingnan", "Liu\nChuanrong", "Ren\nTianming", "Wang\nXiaoying", "Yang\nQiuhong", "Yang\nZhichao", "Yang\nYan", "Yang\nSong", "Gu\nJingkai", "Hu\nChangwen"]}}